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Meningiomas are slow-growing brain tumors derived from the meninges. In 
this study, meningioma cells in culture, and the expression of nm23-Hl gene and 
progesterone receptors as well as their relationship with nuclear matrix were 
investigated. Meningioma cells in culture appeared to be polygonal in shape and 
usually grew in cluster. They usually had abnormal number of chromosomes. By 
comparing the growth rate of normal meningeal cells in culture, meningioma cells in 
culture grew faster than their normal counterpart. The growth of prolonged cultures 
slowed down and cell death occurred. 
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Under transmission electron microscope, meningioma cells in biopsy had a 
different morphology compared to normal meningeal cells which were well-organized 
in connective tissue. Tumor cells lost their tissue architecture. Myriad cell processes 
on the cell membrane, large vacuoles, intermediate filaments and abundant 
mitochondria in the cytoplasm were observed. Tumor cell nuclei showed abnormal 
condensation of chromatins. In cultures, tumor cells appeared to be irregular in shape 
with abundant processes extending from cell membrane. In the cytoplasm, abundant 
mitochondria appeared in laminated form and showed loss of intemal 
compartmentation. Cell nuclei were irregular and highly lobulated. The high cellular 
activity of tumor cells is reflected by abundant euchromatins. 
Nuclear matrix extraction with ammonium sulfate was used to obtained the 
nuclear matrix - intermediate filament structure. Both intermediate filaments and 
nuclear matrix were filamentous in nature. Intermediate filaments were localized in 
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cytoplasm that were associated with the nuclear envelope and further connected to 
nuclear matrix inside the nucleus. Nuclear matrix was composed of nuclear lamina, 
internal matrix fibres and nucleolar residual. The complexities and differences of 
components between intermediate filaments and nuclear matrix were observed by 
SDS-polyacrylamide gel electrophoresis. 
In addition, immunohistochemical study on meningioma in paraffin sections 
showed an increase of nm23-Hl expression with tumor aggressiveness in female 
patients only, but not in male patients. Results of Western blotting of total cellular 
proteins against anti-nm23-Hl antibody and RT-PCR also demonstrated that benign 
<r 
meningioma cells expressed more nm23-Hl than their normal counterparts. Results of 
immunostaining and Western blotting showed that nm23-Hl proteins were localized 
in the intermediate filaments in the perinuclear regions of the cytoplasm. By South-
West blotting, four weak association sites of nuclear matrix proteins with nm23-Hl 
cDNA were found. 
Immunohistochemistry of paraffin sections showed nuclear expression of 
> 
progesterone receptors, but not estrogen receptor, in the nuclei of meningioma cells. 
However, no obvious expression of progesterone receptor was found in cultured cells. 
The expression of progesterone receptors in the nuclear matrix proteins of cultured 
cells was only found by Western blotting. 
The phenomenon of an increased nm23-Hl expression with tumor progression 
in meningiomas needs to be further investigated. The co-existence of nm23-Hl cDNA 
iii 
and progesterone receptors within the nuclear matrix component suggests their close 






The terms and their abbreviations which frequently appear in the text of this thesis are 
listed below: 
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Chapter 1: Introduction 
Cancer is one of the common diseases in Hong Kong. Our knowledge about 
cancer is still very limited. In the past decades, most of the studies were focused on 
the morphological, physiological and molecular aspects of cancers. Prevention of 
cancer is difficult. The development of cancers is believed to involve changes in 
cellular activities. Cell mutation is usually induced by genetic alterations during cell 
division, or carcinogenic chemicals that cause alterations in tumor suppression genes, 
and/or proto-oncogenes. Failure of cancer treatment is usually due to the metastasis of 
cancer cells. Cancer cells lose their normal controls of growth and differentiation, and 
tr 
are proliferating abnormally. It is a stepwise process starting from a single abnormal 
cell and develops into a primary tumor. These abnormal cells are believed to have 
undergone a series of mutations. In some cases, changes or mutations in tumor 
suppressor genes, proto-oncogenes and genes controlling metastasis result in further 
phenotypic changes which lead to tumor progression (Sheeler 1987). 
Meningioma is mainly a benign and slow-growing primary tumor of the 
nervous system. Its occurrence is approximately 40 cases per year in Hong Kong 
indicating that it is not a common ,cancer. It is derived from the arachnoid layer of 
meninges (Schiffer 1993). The World Health Organization (WHO) classifies this 
tumor into four different grades according to its aggressiveness: benign, atypical, 
anaplastic and sarcomatous (Sutherland 1991). In our study, meningiomas of benign, 
atypical and anaplastic grades were used. Meningiomas are found to be female 
dominant with a ratio of 3 : 1 between female and male. Moreover meningiomas are 
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steroid hormone dependent meaning that their growth can be stimulated by steroid 
hormones, mainly progesterone (Morgan 1991; Olson 1987). 
nm23-Hl is a novel gene having the metastasis-suppression function. In some 
carcinomas, such as breast carcinomas, nm23-Hl expression decreases with the 
disease progression. Transfection of nm23-Hl cDNA into a highly metastatic 
melanoma cell shows a 10-fold reduction of metastatic potential (Leone 1991a). One 
of the aims of this study was to investigate nm23-Hl expression in meningiomas with 
respect to their malignancy. Immunohistochemical studies on paraffin-embedded 
sections and cell cultures were carried out. Besides, Western blotting of cell total 
proteins on nm23-Hl and reverse-transcription polymerase chain reaction were used 
in nm23-Hl quantification in meningioma cell cultures. 
Furthermore, the relationship between the nm23-Hl and nuclear matrices of 
cells in culture was also studied. Nuclear matrix is defined as the nuclear structure that 
is resistant to extraction by non-ionic detergents and high salt buffers. Under the 
electron microscope, nuclear matrix can be visualized as a filamentous network 
system. Nuclear matrix plays an important role in cellular activities. It is believed that 
nuclear matrix takes part in the anchorage of DNA in interphase nucleus and mitotic 
chromosomes. Transcription, splicing, processing and nucleo-cytoplamic transport of 
mRNA, and DNA replication can be facilitated by nuclear matrix. Apart from 
providing a skeletal support to the nucleus, nuclear matrix is connected to the 
intermediate filaments in the cytoplasm in order to maintain cell shape and cell 
motility (Amos 1991; Jack 1992; Kaufmann 1986). We intended to show the 
association of nm23-Hl with nuclear matrix. 
Meningiomas are also known to be steroid hormone dependent and recent 
studies have showed that steroid hormone receptors were localized in nuclear matrix 
2 
(Barrack 1987c). We also investigated the expressions of steroid hormone receptors, 
such as progesterone and estrogen receptors, and their relationship with nuclear matrix 
in meningiomas by using techniques such as immunohistochemistry and Western 
blotting of nuclear matrices. 
• 
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Chapter 2 : Literature Review 
2.1 Meningiomas Review 
2.1.1 Origin of Meningiomas 
Meningioma is mainly a prototypical benign nervous system tumor. It is 
derived from the arachnoid layer of the meninges. The meninges consist of three main 
layers: the outermost dura mater, arachnoid and the innermost pia mater. The dura 
mater and pia mater are formed by connective tissues with parallel and interwoven 
fibers, fibroblasts and large cells within the interstices. Between these two layers is the 
arachnoid layer which is formed by interwoven fibrils, fibroblasts, lymphocytes and 
histocytes. In addition, there is a thin layer, external to the arachnoid layer, containing 
epithelial-like cells with a covering function called meningothelial cells. The 
meningothelial cells directly hold the inner dura layer and external arachnoid layer 
together. Sometimes, meningothelial cells form whorls and undergo calcification. 
There is, in general, agreement that meningiomas are derived from the meningothelial 
layer of arachnoid, but other cellular components of the arachnoid, for example 
fibroblasts, may also be found in the inner layer and contribute to their composition. 
This leads to the biphasic, meningothelial and fibroblastic appearances in 
meningiomas (Schiffer 1993). Moreover, recent embryologic studies of the formation 
of the leptomeninges suggest that the origin of meningiomas includes both ectoderm 
(meningothelial cells) and mesoderm (cells forming and present in the walls of blood 
vessels in the subarachnoid space) (Rahilly 1986). 
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Several different attempts in classification of meningeal tumors have been 
made in the past. Current classification divides meningeal tumors into two groups: 
neuroectodermal and mesodermal origin (Chason 1991). 
2.1.1.1 Neuroectodermal Origin 
Those meningeal tumors arisen from the arachnoid capsular cells are classified 
as neuroectodermal origin and are called meningiomas. Most of the tumors are firm, 
thinly encapsulated, and round to hemispheric. They have a nodular surface and a 
flattened edge at their attachment to the dura. Meningiomas of this origin can be 
classified into several types according to their sites of formation, appearance and 
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Structure. They consist of the following types: Meningothelial (syncytial), transitional, 
fibrous, papillary, psammomatous, secretory, myxoid and lipomatous. Meningothelial, 
transitional and fibrous types are more common. Meningothelial type gives 
characteristics of an epithelial cell, and fibrous type has fibroblastic appearance. 
Transitional meningioma is intermediate between meningothelial and fibrous 
meningiomas. It carries both epithelial and fibroblastic characteristics. It is believed 
that meningothelial meningiomas would undergo some changes to become transitional 
type, and further change to fibrous type (Chason 1991; Rubinstein 1972). Most of 
these meningiomas are classified as benign tumors. 
2.1.1.2 Mesodermal Origin 
According to Chason (1991), meningeal tumors derived from cells forming 
the walls of blood vessels, are hemangioblastomas and hemangiopericytomas; and 
cells in blood vessel adventitia and adjacent connective tissues, are chondromas, 
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chondrosarcomas, fibrous histocytomas, osteogenic sarcomas, choroid meningeal 
tumors, lymphomas and lipomas. 
2.1.2 Histopathologic Features 
The World Health Organization (WHO) sets an international histopathologic 
classification for meningiomas. The WHO classifies meningiomas based on six 
criteria of meningioma cells: hypercellularity, loss of architecture, nuclear 
pleomorphism, mitotic index, focal necrosis, and brain invasion. The numeric 
summation of these six criteria classifies a tumor as Grade I to Grade FV, with 
differences based on histologic aggressiveness. Grade I and n represent the benign and 
<r 
atypical type meningiomas, while grade HI and IV represent the anaplastic and 
sarcomatous types which are classified as malignant meningiomas. With the exception 
of brain invasion, each of the criteria is graded from 0 to 3. The higher the number, 
、、 
the more prominent the features. Brain invasion is either histologically absent (0) or 
present (1). Malignant meningiomas are either anaplastic (Grade ffl, with a WHO 
score of 7 to 11) or sarcomatous (Grade IV, with a WHO score greater than 11). 
(Sutherland and Sima 1991). 
2.1.3 Occurrence of meningiomas 
2.1.3.1 Frequency 
Meningiomas represent 18% among intracranial tumors, and 25% among 
intraspinal tumors (Rubinstein 1972; Russel 1977; Schiffer 1993). Multiple 
meningiomas are encountered in 5% to 10% of all cases (Donald 1994). For the 
geographic distribution, it is so uniform throughout the world, with the exception in 
Africa，that seems to have a higher frequency in getting meningiomas (Schiffer 1993). 
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The incidence rate of meningioma is very low. There are average about 1.15 cases per 
100,000 in southern England, less than 1 per 100,000 in Washington, and as high as 
5.4 cases per 100,000 in Rochester (Sutherland and Sima 1991). 
2.1.3.2 Age 
Meningiomas are clearly more common in adults. Low incidence rate is found 
before age 40. After 40, the incidence increases and reaches the maximum in 70 to 79 
years of age. Previous reports showed that meningiomas tend to occur more frequently 
in patients over the age of 60 years. With advanced age, the higher percentage may be 
expressive of the high frequency of incidental meningiomas (Schiffer 1993). 
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2.1.3.3 Sex 
Meningiomas are found to be female-dominant. Beyond 40 years of age, a 
predominance in women is noted. And the incidence rates for men and women begin 
to converge beyond 60- to 69-year age group (Sutherland and Sima 1991). Other 
surveys also report female-dominance in meningiomas (Nakasu 1987; Wood 1957). 
The ratio of incidence in male to female is about 1:3. Such observations indicate a 
relationship between meningiomas and endocrine hormones (Sutherland and Sima 
1991). 
2.1.4 Genetics Aspects of Meningiomas 
Cytogenetic analysis of meningioma cells reveals that most of the 
meningiomas are monosomy 22 (loss of one copy of chromosome 22). Sometimes, 
partial loss of chromosome 22, translocation between chromosome 14 and 22, and 
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loss of chromosomes 8，14 and 17 are reported. Most of the meningiomas are 
sporadic, and familial meningioma report is rare (Atkinson 1991). 
2.1.5 Meningiomas and Steroid Sex Hormones 
By several clinical and epidemiologic observations, meningiomas were 
suggested to be hormonally responsive tumors. It was found that meningiomas are two 
to four times more common in women than in men, and sometimes progress 
symptomatically during the luteal phase of the menstrual cycle or during pregnancy 
(Donald and Cahill 1994). There is a greater chance of association between the 
occurrence of meningiomas and other steroid sex hormone dependent tumors or 
4T 
cancers, such as breast cancers (Mehta 1983; Schoenberg 1975). 
The study of steroid sex hormones in meningiomas started in the last two 
decades. The expression of estrogen receptors in meningiomas was first reported in 
1979 (Donnell 1979). In the past decades significant cytosolic or nuclear estrogen 
bindings were reported in average of 40% of meningiomas (Glick 1983; Lee 1989; 
Magdelenat 1982; Martuza 1981; Martuza 1985; Poisson 1983; Yu 1982), whereas 
others reported absent or low estrogen binding (Brentani 1984; Cahill 1984; Grunberg 
1987; Lesch 1986; Markwalder 1984; Meixensberger 1992; Moguilewsky 1984; 
Schnegg 1981; Tilzer 1982). A general consensus emerged that the presence of 
estrogen receptors in meningiomas occurs in about 30% of cases (Donald and Cahill 
1994). But progesterone binding activity is detected in 40% to 100% of tumors 
(Blankenstein 1983; Brentani 1984; Cahill 1984; Hayward 1984; Lesch and Fahlbusch 
1986; Markwalder 1984; Martuza 1981; Martuza 1985; Meixensberger 1992; 
Moguilewsky 1984; Poisson 1980; Schrell 1990; Tilzer 1982; Vaquero 1983; Yu 
1982). 
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Steroid sex hormones, such as progesterone and estrogen, play an important 
role in the growth stimulation of meningiomas. Previous reports showed that 
meningiomas became symptomatic at high circulating progesterone level. Blocking of 
estrogen receptors showed a high predomination of growth stimulation by 
progesterone (Morgan and Olson 1991). Moreover, applying anti-progesterone agents 
resulted in tumor inhibition (Olson 1987). But the mechanism of such interaction of 
steroid sex hormone receptors in meningiomas remained unknown. Recent 
investigations showed that steroid hormone might diffuse into the cell nucleus and 
bind with specific receptor that effected on gene expression of some unknown 
proteins. These changes in protein synthesis and turnover lead to changes in protein 
<r 
profiles, and finally resulted in the formation of meningioma (Morgan and Olson 
1991). 
、、 
2.1.6 Establishment of Meningioma Cell Lines 
In 1984, Rolf et al. successfully established a human meningeal cell line in 
culture (Korsgaard 1984). In such experiment, tumor nodules of human metastatic 
sarcomatous meningiomas were removed from the patient. They were trimmed and 
cloned in Basal Medium Eagle (BME) with 15% fetal bovine serum and antibiotics 
which was incubated at 3TC in 5% C 0 2 balanced with air. Clones with abnormal 
chromosome stemlines were injected in nude mice of the NMRI and BALB/c strains. 
Tumor nodules formed in mice were minced and established into cell lines in culture. 
This tumor cell culture gave a pronounced cellular polymorphism with 
hyperchromatic nuclei. 
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2.2 nm23 Gene-Review 
2.2.1 Discovery of nm23 gene 
A newly defined human gene, nm23, was first described by differential 
screening of cDNA library with RNA from low and high metastatic clones of a murine 
melanoma cell line in 1988 by Steeg (Steeg 1988a). Then, in 1991, the second isoform 
of nm23 was discovered (Stahl 1991). These two isoforms of nm23 gene were so 
called nm23-Hl and nm23-H2 respectively. Somatic cell hybrid analysis and 
fluorescence in situ hybridization showed the two nm23 isoforms were localized at 
17q22 (Backer 1993). This human nm23-Hl DNA had 8461 base pairs of nucleotides 
(Dooley 1994; Rosengard 1989) and its mRNA was sequenced as 576 base pairs ^ 
(Wang 1993) and is listed as follows: 
1 tgctgcgaac cacgtgggtc ccgggcgcgt ttcgggtgct ggcggctgca gccggagttc 
61 aaacctaagc agctggaagg aaccatggcc aactgtgagc gtaccttcat tgcgatcaaa 
121 ccagatgggg tccagcgggg tcttgttgga gagattatca agcgttttga gcagaaagga 
181 ttccgccttg tgggtctgaa attcatgcaa gcttccgaag atcttctcaa ggaacactac 
241 gttgacctga aggaccgtcc attctttgcc ggcctggtga aatacatgca ctcagggccg 
301 gtagttgcca tggtctggga ggggctgaat gtggtgaaga cgggccgagt catgctcggg 
361 gagaccaacc ctgcagactc caagcctggg accatccgtg gagacttctg catacaagtt 
421 ggcaggaaca ttatacatgg cagtgattct gtggagagtg cagagaagga gatcggcttg 
481 tggtttcacc ctgaggaact ggtagattac acgagctgtg ctcagaactg gatctatgaa 
541 tgacaggagg gcagaccaca ttgcttttca catcca 
The sequence of nm23-Hl mRNA started from the 5'-starting base pair to the 3'-
576th base pair. This nm23-Hl mRNA was obtained from human (Homo sapiens). 
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2.2.2 nm23 Proteins 
Both the nm23 isoforms cloned for proteins with about 17 kilodalton of 152 
amino acids, and with 90% identical to each other (MacDonald 1995; Stahl 1991; 
Varesco 1992). It was reported that the biochemical structures of nm23-Hl and -H2 
proteins are identical to the nucleoside diphosphate kinase (NDPK) A and B chains 
respectively (Gilles 1991). Moreover nm23 proteins are of 77% homologous to the 
Gipl7 proteins, a conclusively identified NDPK in Dictyostelium discoideum', and 
75% homologous to the Drosophila melanogaster abnormal wing discs (awd) proteins 
which regulates the cell morphology, and brain and ovaries development in 
Drosophila (MacDonald 1995; Wallet 1990). These two human nm23 proteins are 
«r 
similar in molecular weight and identical to the NDP kinases, but they perform 
different function. 
The actual function of nm23 protein has not been established, but some 
biochemical properties involved in cellular regulation were suggested as follows: 
2.2.3 Nucleoside Diphosphate Kinase (NDPK) Activities 
Since nm23 proteins are identical to nucleoside diphosphate kinase, so they 
carry the NDPK activities, which catalyzes phosphorylation of 5'-diphosphate to 
corresponding triphosphates. It is believed that a nm23-phosphohistidine intermediate 
may be involved in such phosphorylation: 
N,TP + N2DP — NiDP + N2TP 
The NDPK performs several functions in cellular regulations such as to maintain the 
nucleoside triphosphate (NTP) pools, to supply the NTP during RNA and DNA 
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synthesis, to regulate the cell proliferation, to activate the G protein, and to control the 
microtubule assembly in cells (Gilles 1991; MacDonald 1995; Sato 1987). 
2.2.4 Role of nm23 in Differentiation 
Generally, nm23 has been reported to participate in normal development and 
differentiation in Drosophila and murine. It was found that nm23 gene is 77% 
identical and 96% homologous in predicted amino acid sequence to the Drosophila 
awd gene and its protein product respectively. In normal state, the awd gene regulates 
the cell morphology and differentiation of the brain, ovaries and presumptive adult 
tissues in the imaginal discs postmetamorphosis (MacDonald 1995). Transformation 
«r 
of the mutant awd gene line with the wild type awd gene might induce the abnormal 
differentiation and development in Drosophila (Timmons 1993). 
In murine, low nm23 expression was found before organogenesis. But after 
、、 
this time point, increased nm23 protein levels were observed in the brain and heart 
and most epithelial tissues. Moreover nm23 also correlated with the differentiation in 
mammary glands. Differentiation of mammary glands begins after birth, nm23 
expression is low in presumptive mammary bud and increases in the nulliparous and 
pregnant adult mammary glands (Lakso 1992). 
2.2.5 Role of nm23 in Cell growth 
Two isoforms of nm23 proteins have different distinct functions, but they 
seemed to share some functions in cell growth. One of them, nm23-Hl, was related to 
cell proliferation (Keim 1992; MacDonald 1995). In a study of two-dimensional gel 
electrophoresis, nm23-Hl was designated as pl9/nm23 protein in neuroblastomas 
(Hailat 1991). This protein, basically, stimulates cell mitosis. In normal lymphocytes, 
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the amount of p l9 increased in response to mitotic stimulation, and during DNA 
synthesis. In leukemia cells obtained from patients with acute leukemia, the pl9/nm23 
levels were higher compared to the normal lymphocytes. While treating the normal 
lymphocytes with cyclosporin, a proliferation inhibitor, the increase in pl9/nm23 was 
blocked. Moreover treatment of the leukemia cell line HL-60 with dimethylsulfoxide, 
a terminal differentiation inducer, resulted in diminished levels of pl9/nm23 (Keim 
1992). Besides, some observations suggest both isoforms of nm23 gene are related to 
cell growth. Results of immunohistochemistry showed that nm23 proteins were 
abundant in the mitotic spindle microtubules (Dearolf 1988). Injection of nm23-
specific antibodies into rat embryo fibroblasts could inhibit cell division (Sorscher 
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1993). Furthermore, the level of nm23 gene expression was paralleled to the fraction 
of cells incorporating thymidine in neoplastic mammary tissues. In human breast 
epithelial cell line, MCF-lOA, nm23-Hl mRNA reached the maximum amount in the 
S-phase and was absent or only present at very low levels during Go/Gi phase, 
whereas nm23-H2 was present in growth-arrested cells but was up-regulated 
following serum growth stimulation (Caligo 1995). 
2.2.6 Role of nm23-Hl in Tumor Metastasis 
Tumor metastasis is a complicated and multi-step process by which a group of 
tumor cells gain the ability to leave a primary tumor and colonise in other sites of the 
body. This process involves the dissemination of metastasising cells from the primary 
tumor, traveling in blood vessels, invasion of surrounding tissue, intravasation, arrest, 
extravasation, and initial angiogenesis and colonisation in secondary sites, with the 
evading of the immune system (MacDonald 1995). 
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The molecular regulation of the tumor metastasis process has not been defined, 
but the development of prognostic and therapeutic advances is in progress. Recently 
nm23 gene was used as a marker correlating with the tumor metastasis in several 
cancers. In human breast, hepatocellular, ovarian and gastric carcinomas and 
melanomas, nm23 expressions were found decreasing with the increase in tumor 
metastatic potential. On the other hand, an inverse observation was obtained in 
neuroblastomas and pancreatic carcinomas. Moreover, nm23 expression was not 
associated with disease progression in lung and colorectal carcinomas (MacDonald 
1995). 
2.2.7 Transfect'ion of nm23-Hl 
The nm23-Hl expression not only affects the phenotype in tumors with respect 
to metastasis, it also takes part in the regulation of metastasis in some tumors, ]n 
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order to investigate whether there is a cause-and-effect relationship between the 
nm23-Hl expression and tumor aggressiveness, Leone first introduced the 
transfection of murine nm23-l cDNA into the murine K-1735 TK melanoma cells. 
Compared with the control group with an transfected empty vector, the nm23-Hl 
transfectant exhibited a 50-90% reduction in metastasis (Leone 1991a). The 
transfection of human nm23-Hl cDNA intoB16F10 malignant murine melanoma cell 
lines also gave a significant reduction in invasive and metastatic potential in vivo 
(Parhar 1995). 
Leone (Leone 1993a) successfully introduced the same technique in human 
MDA-MB-435 breast carcinoma cell line. Generally, the human MDA-MB-435 breast 
carcinoma cell line itself expresses relatively low nm23-Hl, and it causes breast 
cancer metastasis after the injection into the mammary fat pad of nude mice. In the 
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same study, the nm23-Hl cDNA was subcloned into the BamHI site of the pCMV 
plasmid, and was transfected into the human MDA-MB-435 breast carcinoma cell line 
with a plasmid without any insert acted as a control. The control transfectants 
produced 50-59% of lymph node or pulmonary metastasis, while the nm23-Hl 
transfectants reduced the percentage of metastasis to 19% and 5%, respectively. 
Therefore nm23-Hl was proposed to be a metastatic suppressor gene. 
Using human MDA-MB-435 breast carcinoma cell line and murine K-1735 
TK melanoma cell line as models, studies have shown no significant difference in the 
culture morphology, growth rate, protease production nor adhesiveness between the 
control and nm23-Hl transfectants (Howlett 1994; Leone 1993a; Leone 1991a). On 
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the other hand, control transfectants had a greater motility after stimulation by serum, 
insulin growth factor (IGF), and platelet derived growth factor (PDCF) (Kantor 1993). 
In addition, nm23-Hl transfectants exhibited no response to a cytokine, TGF-P, in 
、、 
aberrant colonisation whereas control transfectants were stimulated by TGF-p (Leone 
1993a; Leone 1991a). In distinct organs, colonisation at both the primary and 
metastatic sites may be stimulated by certain external stimuli or internal factors such 
as TGF"P. This colonisation response may be highly relevant to both metastatic 
dissemination and eventual therapeutic intervention into the metastatic process 
(MacDonald 1995). The transfection of human nm23-Hl cDNA caused the reduction 
of colonisation and metastatic potential in different cancer models. 
2.2.8 nm23-Hl Expression Decreases with Tumor Progression 
In 1989’ Steeg first described a decreased nm23 gene expression in highly 
metastatic cells. In their study, K-1735 melanoma cell lines and N-nitroso-N-
methylurea-induced (NMU-induced) rat mammary carcinomas were used as models 
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for analysing the nm23-RNA quantity. In K-1735 melanoma cell lines, with high and 
low metastatic potential, cDNA libraries were constructed and hybridized to K-1735 
cell line RNA. The nm23 cDNA exhibited a 10-fold greater hybridization to RNA 
from low metastatic cell lines than to RNA from related highly metastatic cell lines. 
Moreover, high nm23 RNA level was found in non-metastatic NMU-induced rats 
mammary carcinomas compared with pulmonary metastatic rat mammary carcinomas 
(Steeg 1988a). Before the discovery of the second isoform of nm23 (nm23-H2), 
several reports also described a relatively low nm23 RNA level in highly metastatic 
tumors (Bevilacqua 1989; Steeg 1988b; Wallet 1990). The nm23-H2 was discovered 
in 1991 (Stahl 1991)，and several evidence showed that its function was not related to 
4f 
metastasis. Thus the relationship of nm23-Hl with tumor metastasis became the main 
interest of study. Inverse correlation of nm23-Hl mRNA to disease progression was 
found in murine mammary tumor (Caligo 1992), human breast cancers (Hennessy 
1991), human melanomas (Florenes 1992; Xerri 1994), human gastric carcinomas 
(Nakayama 1993), human ovarian carcinomas (Viel 1995), and human hepatocellular 
carcinomas (Iizuka 1995; Nakayama 1992). 
After the development of polyclonal and monoclonal antibodies for NDP 
kinase A and nm23-Hl, scientists began looking into the nm23-Hl protein expression 
in tumors. Similar to the reports of inverse correlation of nm23-Hl mRNA expression 
to tumor metastasis mentioned above, decreased nm23-Hl protein expression was 
found in human ductal breast carcinomas (Barnes 1991; Kobayashi 1992; Noguchi 
1994)，endometrial carcinomas (Watanabe 1995), melanomas (Hamby 1995), 
laryngeal carcinomas (Lee 1996) and the advance stage of prostatic intraepithelial 
neoplasia and adenocarcinoma (Mandai 1995a; Myers 1996). 
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2.2.9 nm23-Hl Expression Increases with Tumor Progression 
Despite the metastasis-suppression and the decrease in mRNA and protein 
expressions of nm23-Hl, a different behavior of this gene was found in some tumors. 
A relatively high nm23-Hl gene expression was found not to be associated with tumor 
progression in human colonic neoplasms (Haut 1991) and colorectal tumors (Giarnieri 
1995), and directly correlated with the disease progression in pancreatic carcinomas 
(MacDonald 1995) and neuroblastomas (Keim 1992; Leone 1993b; MacDonald 
1995). 
Neuroblastoma is the one that significantly and steadily shows an increase in 
nm23-Hl expression compared with normal lymphocytes. nm23-Hl has been defined 
• 
as pl9/nm23 protein in neuroblastomas, which takes part in cell proliferation activity 
(Keim 1992). In regional (stage ni) and metastatic (stage IV) childhood 
neuroblastomas, an elevated nm23-Hl mRNA level was reported as compared to 
>% 
localized tumors. Genomic amplification of nm23-Hl was associated with the 
increase in nm23-Hl mRNA expression (Leone 1993b), but not in nm23-Hl protein 
in neuroblastomas. Recently, some reports suggested that the reason of such increase 
was due to the molecular alterations to nm23-Hl (Leone 1993b; Takeda 1996). 
2.2.10 nm23-Hl Expression Not Related to Tumor Progression 
In addition to the controversial studies on the role of nm23-Hl in cancer 
metastasis, some cancers, such as carcinomas in bladders (Nakopoulou 1996; Shiina 
1996), pulmonary adenocarcinomas (Higashiyama 1992), renal cell carcinomas 
(Walther 1995), breast cancers (Sastre-Garau 1992), ovarian carcinoma (Mandai 
1995b) gave no relationship between the nm23-Hl expression and disease 
progression. 
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2.2.11 nm23-Hl Messenger RNA and Protein Expression 
Though both the nm23-Hl mRNA and protein seemed to be decreased with 
the tumor metastasis in some cancers, such as breast carcinomas, several evidence 
indicated that the down-regulation of nm23-Hl protein may occur at the post-
transcriptional level. Firstly, some cancers did not show a direct correlation between 
nm23-Hl mRNA and protein levels (Ayhan 1993; Biggs 1990; Leone 1993a). 
Secondly, there is a "ser^^^-gly" mutation in nm23-Hl protein in human 
neuroblastoma as compared to other tumors (Chang 1994). Thirdly, The mutation of 
"killer of prune “ in Drosophila NDPK may affect the protein stability (Lascu 1992). 
Fourthly, phosphorylation of ser^^, ser'^° or ser'^^ by cellular kinase may affect protein 
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functions (MacDonald 1994). Lastly, Hamby et al. (Hamby 1995) recently reported 
that the nm23-Hl protein but not the mRNA level was 5-time lower in metastatic 
melanoma cell lines than in non-metastatic cell lines. Moreover the nm23-Hl protein 
122 �� exhibited a mutation in ser -pro region in metastatic cell lines, which matches the 
seri20-giy mutation of nm23-Hl in human neuroblastoma (Chang 1994). Both 
mutations affect the phosphorylation sites as well as the protein synthesis. This 
suggests that nm23-Hl protein expression is regulated at the post-transcriptional level 
(Engel 1994; MacDonald 1994). 
2.2.12 Roles ofnm23-H2 
The second isoform of human nm23 gene was discovered in 1991 and was 
designated as nm23-H2 (Stahl 1991). Unlike nm23-Hl which is involved in 
metastasis-suppression, nm23-H2 takes part in transcriptional activation of the c-myc 
proto-oncogene (Kraeft 1996). The c-myc is aproto-oncogene which regulates cellular 
proliferation, differentiation, and tumor formation (Kato 1992; Luscher 1990). 
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Expression of the c-myc gene requires a complicated regulatory mechanism (Spencer 
1991). A DNA binding protein, PuF, is known to regulate c-myc transcription in vitro 
(Kato and Dang 1992; Marcu 1992; Spencer and Groudine 1991). PuF was identified 
as a factor which binds to a nuclease-hypersensitive element (NHE) of the human c-
myc promoter for the initiation of such promoter transcription. The PuF regulates 
human c-myc activity by the interaction with structural elements of NHE (Postel 
1989). Interestingly, the purified PuF protein was encoded with 152 amino acids and 
with a molecular mass of about 17 kDa that was more than 95% homogeneous to 
nm23-H2 protein; and PuF cDNA sequence has 99% homology to human nm23-H2 
gene. Thus the nm23-H2PuF protein was reported to specifically regulate the c-myc 
0 
trancription (Postel 1993). 
However no significant correlation has been established between 
overexpression of c-myc and tumor metastasis, nor the inverse relation between c-myc 
expression and cell differentiation was reported (Kato and Dang 1992; Marcu 1992; 
Spencer and Groudine 1991). Takino indicated a significant reduction of both nm23-
H2 mRNA and proteins in invasive tumors, compared with non-invasive ones; high 
expression of nm23-H2 was associated with non-invasive pituitary adenomas and 
might restrain tumor aggression (Takino 1995). For most of the other tumors, no 
report about the significant relationship between the nm23-H2 expression and tumor 
metastasis was found. This implies that nm23-H2 may not be participated in cancer 
metastasis, and its function is independently to the nm23-Hl. 
2.2.13 Localisation of nm23 Proteins 
Several pieces of evidence have shown that two different nm23 proteins are 
localised in the cytoplasmic regions (Ayhan 1993; Barnes 1991; Caligo 1992; 
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Giarnieri 1995; Haut 1991; Hennessy 1991; Howlett 1994; Iizuka 1995; Kraeft 1996; 
MacDonald 1995; Myers 1996; Nakayama 1993; Nakayama 1992; Viel 1995; Wang 
1993; Watanabe 1995). In 1993’ Urano et aL (Urano 1993) tried to analyse the 
subcellular distribution of nm23-Hl and -H2 proteins. In such experiment, 
erythroleukemia cells were fractionated into the membrane, cytoplasmic and nuclear 
matrix fractions, and stained with monoclonal nm23 antibodies. Both proteins showed 
the same distribution profile of 20, 65 and 15% in the membrane, cytoplasmic and 
nuclear fractions respectively. Urano (1993) also found that most hematopoietic and 
several non-hematopoietic cell lines were positive with mAb nm23-Hl which 
suggests the surface expression of nm23-Hl protein in a wide range of cell types. On 
tf 
the other hand, the surface expression of nm23-H2 protein was detected only in a 
limited number of cell lines. 
Nuclear localization of nm23-H2 was also reported. Results of Western 
blotting and immunofluorescence indicated the positive reactivity of nm23-H2 in 
nuclear regions of human fibroblasts and epithelial cells. The subcellular localization 
of nm23-H2 was also examined during different stages of mitosis. In prophase, nm23-
H2 remained in the nucleus but began to dissociate from the condensing chromatin. 
The dissociation continued in prometaphase after the breakdown of the nuclear 
envelope and while at the chrometaphase, nuclear nm23-H2 was most likely 
translocated into the cytoplasmic pool of nm23-H2. The protein remained cytoplasmic 
throughout metaphase, anaphase, and telophase and did not co-localise with 
chromosome. During cytokinesis, when chromosomes decondensed, nm23-H2 
staining was partly restored within the newly formed daughter nuclei (Kraeft 1996). 
20 
2.2.14 Mutation in nm23 genes 
A relatively low level of nm23 gene in metastatic cancers (Ayhan 1993; 
Barnes 1991; Caligo 1992; Giarnieri 1995; Haut 1991; Hennessy 1991; Howlett 1994; 
Iizuka 1995; Kraeft 1996; MacDonald 1995; Myers 1996; Nakayama 1993; Nakayama 
1992; Viel 1995; Wang 1993; Watanabe 1995) and reduction in metastatic potential 
from nm23 cDNA transfectants (Leone 1993a) supported the nm23 gene to be a 
metastasis-suppressor gene (MacDonald 1995). However, a relatively high nm23-Hl 
expression was found in neuroblastomas (Keim 1992; Leone 1993b). The differences 
among nm23 expression in normal tissues, non-metastatic and metastatic cancers may 
be due to the mutation of nm23 gene. Several tumors were reported to have somatic 
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allelic deletion of nm23 gene (Leone 1991b; Leone 1993b; Takeda 1996; Wang 
1993). In human breast, renal, colorectal, and lung carcinoma DNA samples, results of 
Southern hybridization indicated that Bg/II restriction fragments of nm23-Hl DNA 
were lost, as compared to DNA from matched normal counterparts. Besides, a 
homozygous deletion of nm23-Hl was observed in a lymph node metastasis of a 
colorectal carcinoma, indicating that nm23-Hl was recessively inactivated, and its 
expression was down regulated (Leone 1991b). Wang (Wang 1993) also reported the 
mutation in nm23 gene in colorectal cancers. Reverse transcription-PCR sequencing 
of nm23-Hl gene showed its missing in PCR products and a deletion in the 64th base 
pair in colorectal cancer samples with metastasis in lymph nodes, lung or liver. While 
no genetic alteration of nm23-Hl gene occurred in non-metastatic tumors. Thus the 
expression of nm23-Hl was down-regulated in advanced stage tumors compared with 
benign tumors, and even normal tissues. 
The increase in nm23-Hl expression in neuroblastomas may be caused by the 
molecular alteration in this gene. Different from somatic deletion in tumors mentioned 
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above, neuroblastomas usually exhibit an increase in DNA amplification (Leone 
1993b). Such increase may be due to an increase in nm23-Hl copy number in tumor 
cells (Takeda 1996) that causes overexpression of nm23-Hl mRNA, and proteins, 
compared with normal tissues. In addition, there is a "ser'^^-gly" mutation in nm23-
H1 protein in human neuroblastoma as compared with other tumors (Chang 1994), 
and direct sequencing of nm23-H2 in advanced stage neuroblastoma revealed a 
leucine to valine mutation at position 48 (Leone 1993b). These results indicated that 
molecular alterations to nm23 other than its reduced expression can be associated with 
tumor aggressiveness. 
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2.3 Nuclear Matrix-Review 
2.3.1 Cell Nucleus 
The nucleus is an important organelle in all eukaryotic cells. Chromosomes, 
nucleosomes, nucleolus, and nuclear envelope are the major nuclear components 
which provide structural and chemical functions to the nucleus. Structurally, the 
nucleus is covered by a double-membranous envelope consisting of many nuclear pore 
complexes. Within the envelope, chromatins including heterochromatins and 
euchromatins, free riboproteins, nucleolus are found. Chromatins are made up of 
DNA as well as histone proteins. The DNA strands turn around the histone cores to 
form nucleosomes, which then coil into chromatins. Chromosome is formed by the 
association of chromatins and nonhistone chromosomal proteins. During the mitotic 
phase of a cell cycle, chromatins highly condense into chromosomes and can be seen 
under microscope after basic dyes staining. The chromatins are not in condensed state 
22 
in the interphase of a cell cycle. Depending on the staining properties, euchromatins 
can be distinguished from heterochromatins by the light staining, whereas 
heterochromatins give a dark-staining as the chromatins remained in condensed state. 
The nucleolus is the dominant internal feature of the cell nucleus. It is composed of 
RNA and proteins, and is the site of formation of ribosomal constituents (Sheeler and 
Bianchi 1987). Using the EDTA regressive staining, ribonucleoproteins (RNP) are 
observed in nucleus. They may be freely localized in the nucleus and function as the 
transport of newly transcribed extranucleolar RNA (Berezney 1986). 
2.3.2 The Concept of Nuclear Matrix # 
Berezney and Coffey were the first to describe the term "nuclear Matrix" in 
1974 to denote a highly structured residual framework obtained from rat liver nuclei, 
and operationally defined as the nonchromatinic structural proteins and 
ribonucleoprotein network that remains in the nucleus following digestion with 
detergents, nucleases, and high-salt buffers (Berezney 1974). After such digestion, 
most of the nuclear materials such as nucleic acids, proteins and phospholipids have 
been removed. The residual structure is so defined as nuclear matrix. 
Nuclear matrix is an universal feature in all eukaryotic cells. A variety of 
nomenclature has been used by different investigators by using different methods of 
extraction as: nuclear matrix, nuclear framework, nuclear skeleton, nuclear scaffold, 
nuclear ghost, nuclear cage, and chromatin-depleted nucleus. All these terms refer to 
very similar residual nuclear structures (Nelson 1986). 
Under the electron microscope, nuclear matrix can be observed as a 
filamentous network system connecting the nuclear envelope and residual nucleolus. 
Electron dense particles are associated with the matrix fibres. Nuclear matrix does not 
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only provide skeletal support to the nucleus, and it also participates in cellular 
activities such as DNA replication, transcription, RNA processing and nucleo-
cytoplasmic transport of RNA (Jack and Eggert 1992; Kaufmann 1986). 
The major component of nuclear matrix is protein. Some nuclear matrix 
proteins may be common in different cells or tissues, but some are found to be cell 
specific, cancer specific, and even differentiation stage specific. 
2.3.3 Methods of Nuclear Matrix Extraction 
In order to study the organization of nuclear matrix, Berezney and Coffey were 
the first to give the concept of nuclear matrix extraction (Berezney and Coffey 1974). 
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First, an isolated nucleus was treated with non-ionic detergents to permeabilize the 
nuclear membranes. Then high ionic strength buffer was used to extract the nuclear 
histone proteins, with final treatment of nucleases to remove nucleic acids. The 
resulting entity was defined as "Nuclear Matrix". Then several modifications of the 
Berezney and Coffey procedure were introduced to obtain different nuclear matrix 
components. 
2.3.3.1 Extraction with Sodium Chloride 
This type of extraction was introduced by Berezney and Coffey (Berezney and 
Coffey 1974), and is now used in most preparations of isolated nuclei treated with 
nucleases and extracted with buffer of high ionic strength. The bulk DNA was 
removed by concentrated (2M) sodium chloride solution followed by the treatment of 
DNase I. Various parameters, such as the use of RNase and sodium tetrathionate and 
the formation of disulfides, in the isolation procedure were systemically analyzed and 
different resulting matrices were obtained (Kaufmann 1986). 
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2.3.3.2 Extraction with Ammonia Sulphate 
This method uses the ammonium sulphate instead of sodium chloride (Fey 
1986). The starting material is the whole cells rather than isolated nuclei. Therefore, 
these preparations also contain cytoskeletal structures and are called the "nuclear 
matrix-intermediate filament complex". The cells are permeabilized with Triton X-
100 in buffer containing vanadyl ribonucleoside complex as RNase inhibitor to 
prevent the disruption of nuclear framework. Permeabilized cells are incubated with 
RNase-free DNase and extracted with 0.25M ammonia sulphate. Then nuclear matrix-
intermediate filament complex is obtained. 
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2.3.3.3 Extraction with Lithium Diiodosalicylate 
In order to study the attachment of DNA to the nuclear matrix, Mirkovitch 
(1984) used ionic detergent lithium diiodosalicylate (LIS) for the isolation of 
subnuclear structures. The extraction starts with isolated nuclei. Subsequently, 
histones and other nuclear proteins were extracted with LIS and DNA was digested 
with restriction enzymes rather than the non-specific cutting by DNase. The resultant 
product was a "nuclear scaffold" that suits for the study of matrix attachment region 
(MAR) or scaffold attachment region (SAR) in nuclear matrices. 
2.3.3.4 Electroelution of DNA 
Jackson (Jackson 1991) suggested the use of electroelution for nuclear matrix 
extraction to avoid the artifactual precipitation or aggregation of nuclear components 
due to non-physiological high and low ionic strengths of the buffers used. 
Electroelution provides a steady physiological ionic strengths throughout the matrix 
isolation. The cells are embedded in agarose following the DNA digestion by 
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restriction enzymes and DNA removal by electrophoresis. The advantage of such 
method is that the replication and transcription can be completely retained in the 
resulting "nucleoskeletons". 
Each of the above method has it own value. Each method serves to illuminate 
different aspects of the complex nuclear structure and provides an analytical tool for 
the study of nuclear matrix structure and functions. 
2.3.4 Nuclear Matrix Structure and Composition 
Among all the extraction methods, extraction with ammonium sulphate is 
usually for studying nuclear matrix organization and protein composition. In this 
, 
method, cells are treated with Triton X-100, ammonium sulphate or Tween-40 plus 
sodium deoxycholate, DNase I and then ammonium sulphate again to permeabilize 
cell membrane, to release soluble proteins, remove cytoskeleton, digest DNA and 
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elute chromatins respectively (Capco 1982; Fey 1984; He 1990; Jiao 1991). All the 
cytoplasmic materials are removed except intermediate filaments. Subsequently, an 
intermediate filament-nuclear matrix complex is obtained. 
2.3.4.1 Intermediate Filaments 
Intermediate filament (DF), one of the integral components of the cytoskeletal 
framework in eukaryotic cells, is composed of a group of heterogenous protein, ffs 
are all very similar in structure and are known as lOnm filaments due to their rather 
consistent diameters (Amos and Amos 1991). They are highly conserved central a -
helical rod domain of 310-315 amino acids with variable flanking end regions on 
either side that slowly wind around each other (Schoeman 1993; Singh 1994). 
Polymerization of Ws does not require any energy, associated proteins or catalytic 
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factors (Steinert 1985). JFs from different cells types exhibit marked differences in 
their size and antigenicity (Zackroff 1982). It is found that TFs are highly insoluble 
after isolation. Even very high concentration of salts such KC1 fail to dissolve them, 
and denaturing conditions such as 8M urea seem to be needed (Amos and Amos 
1991). 
There are several classes of intermediate filaments, including cytokeratins, 
desmin, vimentin, neurofilaments and glial filaments. Different classes tend to be 
found in different cell types, or in a same cell. They are likely to be attached to most 
membrane bound structures (Mayerson 1981). Certain ffs are attached to cell 
junctions that provide the tensile strength of tissues. Moreover,正 has been reported to 
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be associated with lamins, one of the nuclear matrix components which is localized at 
the inner nuclear membrane for structural support and nucleo-cytoplasmic transport 
(Amos and Amos 1991). 
2.3.4.2 The Nuclear Pore Complex-Nuclear Lamina 
Eukaryotic cell nuclei are double-enveloped structure. The outer nuclear 
envelope extends out to form rough endoplasmic reticulum and is covered with 
ribosomes. The inner envelope is smooth. Nuclear pore complexes are situated in 
those regions where the two envelopes fuse. Nuclear lamina is a fibrillar meshwork of 
proteinaceous material which is intercalated between the chromatin and the inner 
membrane of the nuclear envelope. It is believed that nuclear lamina provides an 
architectural framework for the nuclear envelope and an anchoring site at the nuclear 
periphery for interphase chromatin (Franke 1981b; Gerace 1986). After nuclear 
extraction, the nuclear lamina can be observed to form the residual nuclear envelope 
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that marks the boundary between the external intermediate filaments and the internal 
nuclear matrix. 
2.3.4.3 The Nucleolar Matrix 
Nucleolus is the site of synthesis and processing of pre-ribosomal RNA, and of 
assembly of the ribosomal proteins inside a nucleus. In studying the whole cell by 
transmission electron microscopy, nucleolus can be visualized as a highly dense 
structure inside the nucleus. After the nuclear matrix extraction, a nucleolar matrix 
can be obtained. Thus the nucleolar matrix was defined as the residual nucleolus left 
in nuclear matrix preparation (Jordan 1984). However, little is known about the 
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composition of the nucleolar matrix. The elegant studies of Franke et al. (Franke 
1981 a) led to the isolation of a nucleolar matrix from Xenopus oocyte nuclei 
comprising filaments of about 4nm diameter, which were densely coiled into higher-
order fibrils of 30-40nm diameter. Comings and Peters indicated that most of the 
nucleolar proteins were basic in nature (Comings 1981). The nucleolar matrix fraction 
was enriched in polypeptides with seven different molecular weights (Olson 1986). 
2.3.4.4 The Internal Matrix 
The internal matrix is a reticular meshwork which extents throughout the 
extracted nucleus. It is continuous with the nuclear lamina and is connected to the 
residual nucleoli. Under high power of electron microscopy, the internal matrix can be 
visualized as densely packed fibres associated with electron dense particles. The 
matrix fibres range from 3 to 22nm in diameter. Some granules about 20nm in 
diameter, sometimes occurred in cluster, are attached to the fibres (Capco 1982). 
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These granules are believed to be heterogenous nuclear ribonucleoproteins (hnRNPs) 
and small nuclear ribonucleoproteins (snRNPs). 
By definition, the combination of the nuclear lamina, the internal matrix and 
the nucleolar matrix are defined as the "nuclear matrix". In some cases, due to 
different approaches of the studies, the term "nuclear matrix" may be collectively used 
to described the nuclear scaffold, or the intermediate filament-nuclear matrix 
framework. 
2.3.5 Nuclear Matrix Proteins 
The nuclear matrix proteins are in high complexity. These proteins comprise # 
about 10% of the total nuclear protein mass and compose of a subset of nonhistone 
proteins (Nelson 1986). Over 200 proteins in the nuclear matrix were detected by two-
dimensional gel electrophoresis (Fey 1988). Despite the complexity, nuclear matrix 
proteins can be classified into two major types: (1) those which are commonly found 
in a variety of cell lines, and (2) those which are both cell type dependent and 
differentiation state dependent (Dworetzky 1990; Fey and Penman 1988; Stuurman 
1990). Only a small portion of nuclear matrix proteins have been identified. 
2.3.5.1 Nuclear Lamina 
Nuclear lamina is localized surrounding the inner nuclear envelope. There are 
three different types of nuclear lamina proteins: lamins A, B and C. The lamina is a 
highly dynamic structure, dissociates at prophase and reassembles at telophase. 
During cell division, nuclear membrane disintegrates and all three lamins become 
monomeric. Lamins A and C are in soluble and non-membrane-associated state, 
whereas lamin B is associated with membrane fragments derived from the 
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disassembled interphase nuclear envelope. The depolymerized proteins are recycled in 
the formation of the daughter cell nuclear envelopes (Gerace 1980). 
The name of lamins A, B and C are defined in the order of decreasing 
molecular mass. Lamins A and C are neutral in pI value, but have different molecular 
weights: lamin A is 70kDa and lamin C is 70 kDa. While lamin B is acidic in nature 
and it is 67 kDa in molecular weight. They represent 10 to 20% of the total nuclear 
matrix proteins. The amino acid sequences of lamins A and C are quite homologous, 
but lamin B has a different peptide map (Gerace and Blobel 1980; Kaufmann 1986; 
Nakayasu 1991). Besides the structural similarity, lamins A and C are both DNA 
binding proteins (Berenzey 1991; Hakes 1991a). They specifically bind to mitotic 
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chromosome surfaces and assemble into a supramolecular structure during cell 
division. It is believed that this association is important for the interphase 
chromosome structures as well as the nuclear envelope reformation (Glass 1990). ki 
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contrast, lamin B does not bind to any DNA, but it appears to have specialized 
membrane-binding effect (Gerace 1986). Moreover, lamin B constitutes an 
intermediate filament attachment site that provides a connection between the 
intermediate filaments and nuclear lamina (Georgatos 1987). 
2.3.5.2 Internal Nuclear Matrix Proteins 
The internal nuclear matrix is so complex that it consists of many proteins. Fey 
and Penman (1988) reported that different matrix proteins were found in different cell 
lines. In 1991，Nakayasu and Berezney identified eight major nuclear matrix proteins 
which are different from the nuclear lamina and are conserved among different 
mammalian cells. These eight proteins are matrins 3’ 4，12, 13, D, E, F and G. It was 
showed that the matrins D, E, F, G and 4 were specific DNA binding proteins (Hakes 
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and Berezney 1991a; Hakes 1991b). In addition to the matrins, heterogeneous nuclear 
ribonucleoprotein (hnRNP) and small nuclear ribonucleoprotein (snRNP) particles are 
found in internal nuclear matrix. The monomer of hnRNP particle is of 30S-40S. 
These particles may be associated with the filamentous nuclear matrix fibres (7nm 
thick), or in freeing state (20-25nm diameter) that floats within the matrix (Holoubek 
1984; LeStourgeon 1981). The size of snRNP particles is about 3-times smaller than 
hnRNP (lOS). However, these particles are partly found in association with larger 
particles (30S-60S) containing hnRNA (Padgett 1986). It is believed that 
ribonucleoproteins are important for the transport of newly transcribed RNA from the 
sites of chromatin transcription to final release through the nuclear pore complexes 
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(Berezney 1986). 
Other internal nuclear matrix proteins include the nuclear actins (Manley 
1980; Scheer 1984), DNA a & P polymerases (Foster 1985; Nishizawa 1984; Smith 
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1984)，topoisomerase I (Nishizawa 1984), topoisomerase E (Berrios 1985; Halligan 
1984), RNA polymerase II (Lewis 1984), poly(A) polymerase (Schroder 1984), DNA 
methylase (Burdon 1985) and DNA primase (Tubo 1987a; Tubo 1987b; Wood 1986) 
that play an important role in RNA and DNA metabolism. 
2.3.6 Cancer Specific Nuclear Matrix Proteins 
Despite the complexity of the nuclear matrix proteins in different cells, some 
matrix proteins are cancer-specific. By comparing the patterns of high resolution two-
dimensional gel electrophoresis of normal and tumor cells, Getzenberg et al 
(Getzenberg 1991) identified ten matrix proteins as unique to normal prostate, while 
five proteins were specific to cancer cells. Transformation of cells also led to the 
change in nuclear matrix protein expression (Partin 1993). Moreover, cancer specific 
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matrix proteins were formed in breast (Khanuja 1993), colon, (Keesee 1994), ovarian 
and cervical cancers (Yang 1995). 
2.3.7 Differentiation Specific Nuclear Matrix Proteins 
The nuclear matrix proteins may also be differentiation state dependent. A 
great difference in matrix proteins between in vitro differentiation, or retinoic acid-
induced-differentiation ofP19 embryonal carcinoma cell lines and the undifferentiated 
counterpart was observed (Stuurman 1989). Alteration in matrix protein expression 
was also found in osteoblast differentiation (Dworetzky 1990). These results showed 
that nuclear matrix plays a functional role in cell differentiation. 
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2.3.8 Functions of Nuclear Matrix 
After the discovery of nuclear matrix by Berezney and Coffey (1975), 
scientists tried to look into the functional role of nuclear matrix in nuclear activities. 
As nucleus is the control centre of a cell which regulates DNA replication, 
transcription and RNA processing, it was found that nuclear matrix is the major 
component involved in many nuclear activities. Besides, it also appears to be the 
intranuclear site for steroid hormone receptor interactions. 
2.3.8.1 For DNA Organization 
DNA strands together with the histone octamers form the lOnm nucleosomes, 
which further coil into 30nm fibres. The next level of organization is through the 
binding of nonhistone proteins, which are now well-identified as nuclear matrix 
proteins. It is believed that DNA forms loops and anchors onto the nuclear matrix 
proteins (Marsden 1979; Pienta 1985; Stuurman 1992). Hence there are regions of 
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DNA that are closely associated with matrix proteins, and these DNA-rich nuclear 
matrices could be obtained after matrix extraction. The sequence on DNA that binds 
to nuclear matrix is known as "matrix Attachment Region (MAR)", or "scaffold 
Attachment Region (SAR)" (Berenzey 1991; Berezney 1986; Paulson 1977). The 
MARy^SAR plays an important functional role in DNA organization, and in DNA 
replication and transcription. 
2.3.8.2 For RNA and DNA Metabolism 
DNA replication is a process of the synthesis of a new double-stranded DNA 
from a template. It starts from a replication fork, with replication factors including 
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DNA polymerases, topoisomerases, and primases. Transcription takes place for the 
synthesis of mRNA by the action of RNA polymerases. A hypothesis has been held 
for a long time that these factors do freely move in the nucleus, and start the 
replication after meeting replication sites (Lewin 1994). But recent studies have 
shown that these factors are not in free-moving state, but are bound to certain sites -
the "nuclear matrix". The interaction between MARs and matrix are evolutionary 
conserved. No striking sequencial homologies have been found by comparing 
different MARs. They are all A+T rich, and often contain topoisomerase H consensus 
sequence and are located close to enhancer elements (Driel 1991). Evidently, MARs 
shield genes from upstream and downstream cis-acting elements in the genome that 
affect transcription (Klehr 1991). Besides transcription, nuclear matrix may be 
involved in RNA splicing and processing. Primary transcripts are still bound to the 
nuclear matrix rather than released to the nucleoplasm (Hendzel 1995; Xing 1991). 
Factors for RNA splicing and processing such as poly(A) polymerase (Schroder 1984) 
and DNA methylase (Burdon 1985) were reported to localize in the nuclear matrix. 
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Smith et aL (1989) showed that an antibody bound to HeLa cell nuclear matrix protein 
of molecular weight 65.5kDa could inhibit in vitro splicing of an adenovirus precursor 
RNA. After RNA processing, mature RNAs were transported out of the nucleus via 
nuclear matrix filamentous network. The hnRNPs, which attach to nuclear matrix 
filaments, direct the mature RNA out of the nucleus through nuclear pore complexes 
(Berezney 1986;Driel 1991). 
2.3.8.3 For Nucleus Shape Determination 
Nuclear matrix consists of a filamentous network system. Nuclear laminas 
associate with the inner nuclear envelope, which are further connected with internal 
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nuclear matrix filaments and the nucleolar matrix. This nuclear matrix network 
provides a skeletal support to the nucleus in order to maintain the shape of nucleus as 
well as the cell motility (Berezney 1986). 
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2.3.9 Interaction with Steroid Hormone Receptors 
2.3.9.1 General Concept of Steroid Hormone Receptors 
Steroid hormones modulate most of the cellular processes. Glucocorticoids 
have profound effects on metabolism, development, inflammatory, and stress 
responses. Estrogen, progesterone and androgens regulate and modulate numerous 
cellular activities during several developmental processes in human. In adulthood, 
these hormones are necessary for reproductive function, maintenance of bone mass, 
and muscle integrity. However, in combination with other factors, these hormones 
become potent facilitators of cancers (Freedman 1993; Glass 1994; Truss 1993). 
Binding of steroid hormones to corresponding specific receptors can initiate a cascade 
of events that influence cellular function and signaling. Receptors for estrogen, 
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progesterone, androgens, and glucocorticoid have been localized within the cell 
nucleus and are ligand-activated transcription factors, composed of modular 
functional domains. These are regions for transactivation function, for ligand binding, 
and a region comprised of zinc-finger units that bind to DNA (Carson-Jurica 1990; 
Green 1991; Gronemeyer 1991). 
2.3.9.2 Action of Steroid Hormones on Gene Expression 
Steroid hormones passively diffuse into all cells and are preferentially retained 
only in target cells that contain specific receptor proteins. The hormones form stable 
complexes with specific intracellualr receptor proteins that are steroid- and cell-type 
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specific. Ligand binding is a reversible process, and results in an activation of the 
receptor. Receptor activation leads to the changes in conformation itself, and then 
causes changes in post-transcription of other steroid receptors. These processes enable 
the receptor to bind with high affinity to specific sites on chromatin. This is followed 
by transcription of some genes in which proteins act as factors for different regulatory 
functions. These proteins may serve as factors for transcription of structural genes, 
regulate nuclear factors for chromatin structure, transcription and RNA processing, or 
become an enzyme (e.g. kinase) that affects membranes, protein synthesis, protein 
processing and secretion, and enzyme activities (Green and Chamnon 1991; Hager 
1991;Lauber 1995). 
2.3.9.3 Role of Nuclear Matrix in Steroid Hormone Action 
Evidence indicates that nuclear matrix is intimately involved in the regulation 
of several important cellular processes. Steroid receptors have been identified in the 
nuclear matrix of several target tissues in hormone-stimulated animals including rat 
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liver, uterus, prostate, prostate cancer cell lines, hen liver, and human prostate 
(Barrack 1987a; Barrack 1987b; Barrack 1987c). These matrix-associated steroid 
receptor sites display high-affinity, saturable, tissue-specific biding. The majority of 
the receptors are associated with the internal ribonucleoprotein network (internal 
nuclear matrix) of the nuclear matrix structure (Barrack 1980; Barrack 1982; Barrack 
1983). Moreover, the nuclear matrix of steroid target cells contains intact nuclear 
acceptor sites for steroid receptor complexes, and these sites show binding properties 
similar to the chromatin acceptor sites. In addition, the nuclear matrix appears to be 
associated with transcriptionally active genes, and with DNase I-hypersensitive sites 
(Barrack 1987a; Barrack 1987b; Barrack 1987c; Barrack and Coffey 1982; Berezney 
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1984). 
A variety of steroid hormone receptors and their nuclear binding sites are 
associated with nuclear matrix. These include estrogen receptors (Barrack and Coffey 
、、 
1980) and their nuclear binding sites (Metzger 1990), androgen receptors (Barrack and 
Coffey 1980) and their nuclear binding sites (Colvard 1984), mineralocorticoid 
receptor (Stensel 1991) and progesterone receptors acceptor sites (Hora 1986; 
Schuchard 1991a; Schuchard 1991b). 
2.3.9.4 Progesterone and Estrogen Receptors in Nuclear Matrix 
Receptors of female steroid hormones such as progesterone (PR) and estrogen 
(ER) receptors were reported to be localized in nuclear matrices of steroid hormone 
target cells. Recent studies have tried to look into the association these receptors and 
their receptor binding factors in nuclei. One of the factors, termed "receptor binding 
factor - 1 (RBF-1)", which was a unique lOkDa tissue specific, hydrophobic, 
phosphoprotein, was identified as a specific chromatin acceptor protein for PR, but 
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not for ER (Goldberger 1987; Rejman 1991; Schuchard 1991a). 
Immunohistochemistry showed that both RBF-1 and PR were localized within the 
nuclei of epithelial cells of the undifferentiated avian oviduct, and within epithelial, 
glandular and stromal cells of the oviduct following estrogen treatment and cellular 
differentiation (Zhuang 1993). Besides, RBF-1 and PR nuclear binding sites have 
been localized to the oviduct nuclear matrix (Schuchard 1991a). Similar to PR RBF-1, 
ER also has its RBF. A 17kDa candidate acceptor protein for ER in rabbit uterine 
chromatin has similar properties to the PR RBF-1. This 17kDa protein specifically 
binds only ER, but not PR (Lauber 1995; Ruh 1983; Spelsberg 1988). 
Results of South-West blot analysis have revealed that the avian PR-RBF 
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binds to avian oviduct nuclear matrix DNA, suggesting that there is relationship 
among the RBF, PR and steroid hormone-regulated genes. This finding, with 
discovery of progesterone down-regulates the c-myc proto-oncogene mRNA levels, 
prompted investigations to determine the interaction between the RBF acceptor 
protein and PR on activation of c-myc gene (Fink 1988). 
Furthermore, interactions between steroid receptors and RBF involves a MAR-
like sequence, including those for estrogen receptors (Barrack and Coffey 1980; 
Metzger and Korach 1990), androgen receptors (Barrack and Coffey 1980; Colvard 
and Wilson 1984)，progesterone receptors binding sites (Hora 1986; Schuchard 
1991a)，and mineralocorticoid receptors (Stensel 1991). Schuchard et al, (1991) have 
indicated that the up-stream region of c-myc gene contains MAR-like sequences (A-T 
rich). The RBF binds to region of the c-myc gene that also contains a sequence 
reminiscent of a MAR site. Thus there is a complex relationship among the steroid 
receptors, steroid receptor binding factors, and nuclear matrix in terms of gene 
expression and regulation. 
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Chapter 3 : Materials and Methods 
3.1 Meningioma Biopsies 
A total number of 15 meningioma biopsies were obtained from the 
Department of Anatomical and Cellular Pathology, the Prince of Wales Hospital in 
Hong Kong. After the tumors were removed from patients during surgery, they were 
immediately (within 30 minutes) taken for histopathological diagnosis, cell culture, or 
other scientific studies. The tumor tissues were selected and diagnosed by pathologists 
in the hospital. 
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3.2 Cell Culture 
3.2.1 Primary Cell Culture and Maintenance of Cells 
A small portion of the biopsy was trimmed into small pieces for primary 
explant culture. With the use of Dulbecco modified eagle medium (DMEM) (Gibco), 
which was supplemented with 10% fetal bovine serum (Gibco), 500 unit/ml penicillin 
and 500 ^ig/ml streptomycin, the explants were incubated at 2>TC with 5% CO2 
balanced with air and allowed the out-growth of meningioma cells from the explants. 
The level of medium added was just as the same height of explants. While the 
confluent state of cell cultures was reached in culture flask, the cells were washed 
with Hank Balanced Salt Solution (HBSS) and were detached with 0.25% trypsin for 
1 minute at 37°C. Trypsinization was stopped by the addition of medium with serum. 
The explants were washed with fresh medium and transferred to a new culture dish 
with fresh medium for culturing. Detached cells were centrifuged at 1500 rpm for 3 
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minutes. Cell pellet was resuspended with fresh medium and transferred to a new 
culture flask for the maintenance of cell culture. 
3.2.2 Storage of Cell Culture 
For storage, the confluent culture was trypsinized and centrifuged as describes 
above. The cell pellet was resuspended in 1ml freezing medium and kept frozen in 
liquid nitrogen for future use. 
3.3 Growth Kinetics Analysis 
The cultured cells were trypsinized and resuspended with 0.5% trypan blue, # 
and living cells without blue staining were counted. A concentration of 2 X 10^ cells 
per well were seeded in a 24 well-plate. With the change with fresh medium everyday, 
the number of cells was counted at intervals of 24 hours (1-day). The process was 
repeated three times. A total 14-day cell count was conducted. The sigmoid curve of 
growth kinetics was plotted in a graph and the doubling time of cells with different 
passages from different biopsies were compared. 
3.4. Chromosome Analysis 
Cell cultures with 70% confluence were treated with 0.8 |ig/ml cochemid for 6 
hours at 37°C with 5% CO2. Fresh medium was then re-submitted and cultured 
overnight. After removing the medium the rounded up (arrested) cells were detached 
by gently shaking with 0.075M hypotonic potassium chloride solution for 10 minutes 
at room temperature. Detached cells were centrifuged down and fixed with methanol 
and acetic acid in a ratio of 3 to 1 for 15 minutes at -20�C. Fixed cells were 
centrifuged and resuspended with 3:1 methanol and acetic acid mixture. Cell 
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mounting was achieved by dropping the cell suspension onto the slides and allowing it 
to air dry. The number of chromosomes was counted under light microscope after 
staining with Geimsa for 5 minutes. More than one hundred cells were counted in 
each case. 
3.5 Nuclear Matrix Extraction 
The method developed by Fey et aL was used (Fey 1984). In which, cells in 
culture flask were typsinized, and washed with PBS. The cells were resuspended in 
cytoskeleton (CSK) buffer (see Appendix) for 15 minutes at 4 � C . The cells were 
treated with 100 ^ig/ml DNase I and lOO^ig/ml RNase I in digestion buffer (see 
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Appendix) for 30 minutes and terminated by addition of cold ammonium sulfate with 
0.25 M as final concentration for 3 minutes. The resulting nuclear matrix (NM) was 
dissolved in disassembly buffer (see Appendix). The NM solution was dialysed with 
assembly buffer (see Appendix) at 4 � C overnight. After the dialysis, intermediate 
filaments were precipitated due to removal of urea inside the dialysate. The dialysate 
was centrifuged at 42K rpm, 4°C for 1.5 hours. The pellet (intermediate filaments) 
was dissolved in urea-SDS sample buffer. Protein quantification of nuclear matrix 
(supernatant) was performed by using the kit of Bio-Rad Dc Protein Assay (Bio-Rad) 
and ethanol-precipitation at -20�C overnight. The precipitated pellet (nuclear matrix 
proteins) was dissolved in 2D sample buffer. Resolution of protein by SDS-
Polyacrylamide gel electrophoresis and gel staining was performed. 
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3.6 Electron Microscopy 
3.6.1 Transmission Electron Microscopy 
Transmission electron microscopy was used for studying the morphology and 
internal organizations of normal meningeal, meningioma biopsies, and cell cultures. 
Biopsies were trimmed into small piece with lmm'^ in size and washed with PBS. For 
cell cultures, they were trypsinized and centrifuged at 1500 rpm for 3 minutes. The 
cell pellets were washed with PBS. Both the biopsies and cultured cell pellets were 
fixed in 4% glutaraldehyde in PBS buffer for 1 hour at 4 � C . These cells were washed 
three times in PBS (pH 7.2) and post-fixed with 1% OsO4 in PBS for 30 minutes at 
room temperature. After being washed in PBS, the specimens were dehydrated 
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through a series of increasing ethanol concentrations that ended with three changes of 
absolute ethanol. The dehydrated specimens were infiltrated with a mixture of 
absolute ethanol and Spurr resin at a ratio of 1:2, 1:1 and 2:1 for 30 minutes each and 
then with pure Spurr resin overnight at room temperature. The embedding medium 
was allowed to polymerize overnight at 70�C. Ultrathin sections at 60nm thick were 
cut by an ultracut (Reichert-Jung) and collected onto a formvar coated nickel grids. 
Such grids were treated with saturated uranyl acetate in methanol for 5 minutes in 
dark and 2% lead citrate for 3 minutes at room temperature. The sections were 
examined with a transmission electron microscope (Hitachi H-7100FA) at 75kV. 
3.6.2 Scanning Electron Microscopy 
Similar to the procedure in TEM study, cells were fixed and post-fixed with 
glutaraldehyde and osmium tetroxide respectively. The specimens were dehydrated 
with graded alcohol series for 15 minutes each. Then the specimens were treated with 
increasing concentration of absolute alcohol dissolved-freon (20, 40，60，80%) for 15 
41 
minutes each, and ended with three changes of 100% freon. Then critical point drying 
with freon-133 was applied to dry the samples. The specimens were examined under 
the scanning electron microscope (JSM-630IF) at 3kV. 
3.6.3 DGD Study of Nuclear Matrix 
3.6.3.1 Nuclear matrix Organization 
Meningioma cell cultures in culture flasks were trypsinized and centrifuged. 
Cell pellets were washed with PBS. Washed cells were treated with CSK buffer with 
4mM RVC at 4°C for 15 minutes, and were centrifuged at 1300 rpm at 4 � C for 3 
minutes. Cells were treated with reticulocyte Standard Buffer (RSB) (see Appendix) 
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with 2mM RVC at 4°C for 15 minutes, and centrifuged. Treated cells were incubated 
with DB with 50mg/ml DNase I and 2mM RVC at room temperature for 20 minutes. 
Then 0.25M ammonium acetate was applied and centrifuged at 1800 rpm at 4°C for 5 
minutes. Extracted cell pellets were fixed in 2.5% glutaraldehyde in CSK buffer at 
40c for 3 hours. After washing with PBS, 1% 0 s 0 4 was applied at room temperature 
for 1 hour. Fixed cell pellets were washed with PBS and dehydrated through a serial 
increasing concentration of alcohol (70’ 80 and 95%) with final 3 times of absolute 
alcohol. 
3.6.3.2 DGD Thick Sections Preparation 
The dehydrated samples were immersed in n-butanol (n-BA) /ethanol mixtures 
at a ratio of 1:2 then 2:1, followed by three changes in 100% n-BA for 15 minutes 
each. The samples were transferred to diethylene glycol distearate (DGD) through a 
series of DGD/n-BA mixtures of 1:2，2:1 and finally 100% DGD for 30 minutes each 
at 55^C. The specimens, after a change of 100% DGD, were infiltrated at 55°C 
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overnight. The embedded samples were allowed to solidify at room temperature. 
These DGD blocks were cut using glass knives. Sections were picked onto formvar 
coated grids. DGD was then removed by immersing the grids in 100% n-BA at room 
temperature. The grids were returned to absolute ethanol and were freon-critical point 
dried. The sections were examined under JEOL 100 CXH electron microscope (TEM) 
at 80kV. 
3.6.4 Whole-mount Study in Nuclear Matrix-Intermediate Filament Network 
Meningioma cell cultures were grown on sterilized formvar coated nickel grids 
and incubated for two days. After washing with PBS, nuclear matrix extraction was 
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carried out directly on the cells grown on grids. The procedures of extraction and 
dehydration were as the same as that used in DGD study of nuclear matrix. The 
dehydrated samples were treated with alcohol dissolved-freon and processed through 
critical point drying. The nuclear matrix-intermediate filament network was studied 
under TEM. 
3.7. Immunohistochemistry 
A total number of 24 meningioma biopsies of different grades, which were 
obtained from the Department of Anatomical and Cellular Pathology in the Prince of 
Wales Hospital, were studied. The meningioma paraffin sections were deparaffinized 
in xylene and rehydrated through a series of decreasing ethanol concentration with 
final immersion in PBS. Sections were boiled by microwave for 20 minutes with 
O.lM Citrate Buffer pH 6.0. Endogenous peroxidase was removed by applying 5% 
H2O2 in methanol for 5 minutes. Blocking of non-specific binding sites was done by 
incubating the sections with 5% normal goat serum for 1 hour. Anti-human nm23-Hl 
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primary antibody (1:500 ； Seigakagu), anti-human progesterone receptor (1:40 ； 
NovoCastra Lab.) and anti-human estrogen receptor (1:100 ； Serotec) primary 
antibodies, diluted in PBS, were applied at 4°C overnight. Then sections were 
incubated with biotinylated secondary antibody (1:1000 ； DAKO) and peroxidase 
conjugated antibody (1:100 ； DAKO) for 1 hour each at room temperature. The 
labeling was detected by DAB staining. 
3.8 Cell Protein Analysis 
In order to analyse the appropriate protein expression in cell culture, cell total 
protein of the cells was extracted and resolved by gel electrophoresis. Westem 
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blotting and staining with appropriate antibodies were performed. 
3.8.1 Total Cell Protein Extraction 
、\ 
Two meningioma and one normal meningeal cell cultures at passage 5，were 
trypsinized and lysed with buffer containing 8M urea, 2% NP-40 and 2% p-
mercaptoethanol. The proteins were retained by ethanol-precipitation at -20°C 
overnight. Quantification of proteins was done by Bio-Rad Dc Protein Assay. 
3.8.2 One Dimensional Gel Electrophoresis 
Proteins can be resolved according to the molecular weight using Bio-Rad 
Mini-Protean n electrophoresis. lO^ig of proteins dissolved in 2D sample buffer were 
added to an equal volume of 2X SDS sample buffer. The proteins were boiled for 5 
minutes before the SDS-polyacrylamide gel electrophoresis (PAGE). To prepare slab 
gel sandwich, two ethanol-cleaned glass plates were clamped together with 1mm thick 
spacers in between. The sandwich was placed on casting cradle and was pressed 
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tightly against a rubber gasket on the casting cradle to seal the bottom of the 
sandwich. A 12%, or 15% separating gel was poured into the space between the glass 
plates and allowed to polymerise. Then a stacking gel was prepared and pour onto the 
separating gel. Until the gel was completely polymerised, the boiled samples and pre-
stained or unstained protein markers (Bio-Rad) were loaded onto the stacking gel, and 
was electrophoresed in 200V. 
3.8.3 Polyacrylamide GeI Staining 
Gel was place in Fix Solution I containing 40% ethanol and 10% acetic acid 
for 1 hour. The gel was then immersed in Fix Solution E containing 0.5% 
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glutaraldehyde, 0.8M sodium acetate, 8 X 1 0 ' ½ potassium tetrathionate and 30% 
ethanol for 1 hour. After fixation, gel was washed 4 times with Mini-Q water for 15 
minutes each. Then the gel was stained with silver nitrate solution containing 0.01% 
formaldehyde for 30 minutes. The bands of proteins could be retained with buffers 
containing 0.02M potassium carbonate, 0.005% formaldehyde and 0.375|ig sodium 
thiosulfate for color development which was stopped with 0.4M tris solution 
containing 2% acetic acid. 
3.9 Messenger RNA Analysis 
To examine the gene expression, other than the analysis of protein expression 
by Western Blotting, analysis in the mRNA level was also performed. First of all, 
mRNAs from the cells were obtained and changed to cDNA by reverse transcription 
(RT). Then polymerase chain reaction (PCR), by the desired primers, allowed the 
duplication of cDNA. Thus detection of the amplified cDNA level was obtained in 
order to examine the expression of the appropriate mRNA. 
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3.9.1 Cell Total RNA Extraction 
When the confluent state of culture cells was reached, after the medium was 
removed, 1 ml Trizol (Gibco) was added into the flask with gently shaking for 5 
minutes at room temperature. The suspension of the lysed cell was added with 200^il 
of chloroform, with vortex, and lasted for 3 minutes at 4°C. It was then centrifuged at 
12000 rpm at 4°C for 15 minutes. The upper aqueous layer was obtained and added 
with equal volume of isopropyl alcohol for 3 minutes at 4°C. A mRNA pellet was 
obtained after 12000 rpm centrifugation at 4"C for 15 minutes. The pellet was 75%-
ethanol-washed and allowed vacuum dry. After the pellet was dissolved in DEPC-
treated distilled water, quantification of mRNA was done by measuring the 
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absorbance at 260nm. 
3.9.2 Reverse Transcription 
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Reverse transcription is a process to convert a mRNA into its cDNA by the 
reaction with reverse transcriptase enzyme. As the mRNA was dissolved in DEPC-
treated water, 3|ig of mRNA was mixed with PCR buffer, 1.5mM MgCl2, RNA 
inhibitor, random hexamer, reverse transcriptase, and O.lmM dNTPs (PERKDSf 
ELMER). Reverse transcription was done at 42°C for 45 minutes. The products of 
reverse transcription was stored in freezer at -84°C. 
3.9.3 Polymerase Chain Reaction 
Polymerase chain reaction allows the amplification of cDNA exponentially. In 
which standardized 20^il of reverse transcription products were added with PCR 
buffer, 1.5mM MgCl2, O.lmM dNTPs (PERKIN ELMER), and a pair of primers (both 
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sense and anti-sense) with l^ig each. The sequence of the nm23-Hl primers and its 
complementary binding sequence on nm23-Hl mRNA are described later. This PCR 
cocktail was heated at 95°C for 5 minutes. Then 2 units of Taq enzyme was applied, 
and the PCR was started. For reaction amplifying nm23-Hl, 30 cycles consisted of 1 
minute of 95°C for denaturation of cDNA, 1 minute of 55°C for annealing of primers, 
and 1 minute of 72°C for elongation of newly-synthesized DNA strand were applied. 
Finally, 5-minute-72"C was applied for complete elongation of DNA. The PCR 
products were stored at 4°C. 
A pair of nm23-Hl primers, including both sense and anti-sense strands, was 
manufactured and supplied by the Beijing Medical University in China. The 
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designation of the sequence of the primers was referred to the sequence of nm23-Hl 
mRNA by Rosengard, 1989 (Rosengard 1989). Each primer contained 23 base pairs 
and is described as follows: 
Primer 1 (Sense): 5’ ttg agc gta cct cca ttg cga tc 3，，and 
Primer 2 (Anti-sense): 5' ttt gca ctc tcc aca gaa tca ct 3'. 
The binding of this pair of primers to the nm23-Hl mRNA is showed as below: 
1 tgctgcgaac cacgtgggtc ccgggcgcgt ttcgggtgct ggcggctgca gccggagttc 
61 aaacctaagc agctggaagg aaccatggcc aactgtgagc gtaccttcat tgcgatcaaa 
121 ccagatgggg tccagcgggg tcttgttgga gagattatca agcgttttga gcagaaagga 
181 ttccgccttg tgggtctgaa attcatgcaa gcttccgaag atcttctcaa ggaacactac 
241 gttgacctga aggaccgtcc attctttgcc ggcctggtga aatacatgca ctcagggccg 
301 gtagttgcca tggtctggga ggggctgaat gtggtgaaga cgggccgagt catgctcggg 
361 gagaccaacc ctgcagactc caagcctggg accatccgtg gagacttctg catacaagtt 
421 ggcaggaaca ttatacatgg cagtgattct gtggagagtg cagagaagga gatcggcttg 
481 tggtttcacc ctgaggaact ggtagattac acgagctgtg ctcagaactg gatctatgaa 
541 tgacaggagg gcagaccaca ttgcttttca catcca 
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The primer 1 (sense) binds to nm23-Hl mRNA nucleotides from 95 to 117 (single 
underlined), There were two changes in nucleotides of primer 1: The 97th which was 
changed from “ to ’，，and the 107th which was changed from “ to，，. The primer 2 (anti-
sense) complemented to mRNA sequence from 464 to 442 (double underlined), in 
which the nucleotide “ at 463 was changed to，’. These changes of nucleotides in 
primers do not affect the annealing of primers and elongation of cDNA. 
3.9.4 Agarose Gel Electrophoresis 
The PCR product could be resolved by agarose gel electrophoresis. First, a 1% 
agarose gel in one-fold TBE was prepared. 10|il of PCR products was loaded and 
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electrophoresed in 80V for one hour by Mini-Sub Cell GT (Bio-Rad). After 
electrophoresis was completed, the gel was immersed in l^g/ml ethdium bromide for 
15 minutes. The interest band(s) was observed under ultra-violet illuminating light 
box. 
3.10 Bio-Rad Dc Protein Assay 
A kit of Bio-Rad Dc Protein Assay (Bio-Rad) was used to determine the 
quantity of cell total proteins or nuclear matrix proteins. In such assay, bovine serum 
ablumin (BSA) (Sigma) dissolved in assembly buffer after dialysis was used as 
protein standard ranged from 0 to l^ig/ml. In duplicate settings of the protein 
standards and extracted NM proteins, a volume of 25^1 was added with 125^il mixture 
of solution A and solution S. Then 1ml of solution B was added with gently vortex, 
and incubated for 15 minutes at room temperature. Absorbance of 750nm was 
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obtained with a spectrophotometer. The amount of extracted NM protein was 
determined with reference to a BSA protein standard curve. 
3.11 Western Blotting 
After the gel was electrophoresed, the proteins were transferred onto Hybond-
ECL nitrocellulose membrane (Amersham) in 100V for 1 hour at 4°C. The membrane 
was washed with tris buffered saline with 0.1% Tween-20 (TBS-T), and was treated 
with 5% non-fat milk in TBS-T for 1 hour at room temperature. Then the membrane 
was washed with TBS-T and was incubated with anti-human nm23-Hl, 1:500 
(Segakagu), anti-progesterone receptor, 1:40 (NovoCastra Lab.), or anti-estrogen 
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receptor, 1:100 (Serotec) primary antibodies, with approximate dilution overnight at 
40c. After being washed with TBS-T, the membrane was treated with peroxidase-
conjugated sheep against mouse Ig secondary antibody, 1:2000 (Sigma), or with 
peroxidase-conjugated AffiniPure Donkey Anti-Mouse IgM secondary antibody, 
1:5000 (Jackson ImmunoResearch Lab.) for 1 hour at room temperature. The 
interested band(s) was stained with DAB, or stained with ECL detection buffer 
(Amersham) and exposed onto the ECL high performance luminescence detection 
film (Amersham). 
3.12 DNA-Nuclear Matrix Binding Assay 
This technique was used to analyse the DNA binding ability of nuclear matrix 
proteins. It includes two major parts: 
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3.12.1 nm23-Hl PCR Product Elution 
nm23-Hl PCR product was resolved in agarose gel electrophoresis, and was 
eluted with elution buffer for 6 hours at 37�C. Then high speed centrifugation was 
performed to collect the supernatant, and precipitation of nm23-Hl cDNA was 
achieved by mixing the supernatant with 0.05M ammonium acetate, l^ig/ml glycogen 
and absolute alcohol at -20°C overnight. nm23-Hl cDNA pellet was washed with 
70% alcohol, vacuum-dried, and dissolved in TE buffer. Measurement of absorbance 
at 260nm was performed for DNA quantification. 
3.12.2 DNA Digoexigenin (DIG) Labeling 
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2 ^ nm23-Hl cDNA in TE buffer was heated at 95°C for 5 minutes. Then it 
was mixed with hexanucleotide mixture, dNTPs labeling mixture and Klenow enzyme 
(Boehringer Mannheim) for 1 hour at 37°C. The labeling reaction was stopped by 
adding 0.2M EDTA (pH 8.0). DIG-labeled DNA precipitation was achieved by 
applying the reaction mixture with 0.15M lithium chloride in absolute alcohol for 2 
hours at -20°C. The DIG-DNA pellet was vacuum-dried and dissolved in TE buffer. 
3.12.3 South-West Blotting 
SDS-polyacrylamide gel electrophoresis of nuclear matrix proteins was 
performed. The nuclear matrix proteins were transblotted onto nitrocellulose 
membrane (Sigma), which was then immersed in TBS at 4 � C overnight. The 
membrane was washed with South-West blotting buffer and incubated with DIG-
labeled DNA mixture containing 80ng DIG-labeled nm23-Hl cDNA, Ijiig/ml single-
strand DNA and l^ig/ml poly dI dC in South-West blotting buffer at room temperature 
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overnight. The membrane was washed with South-West blotting buffer and then O.lM 
maleic acid (pH 7.5). Blocking agent (Boehringer Mannheim) in O.lM maleic acid 
was applied for 1 hour to block non-specific sites. It was followed by 1:10000 anti-
DIG alkaline phosphate conjugated antibody in blocking reagent for 1 hour. After 
being washed with O.lM maleic acid, the membrane was treated with detection buffer 
for 10 minutes. NBTVBCIP (Sigma) was used as colour-substrate solution for colour 
development. 
3.12.4 Investigation of Binding Affinity of nm23-Hl cDNA to Nuclear Matrix 
Proteins 
0 
South-West blotting of nuclear matrix proteins with DIG-labeled nm23-Hl 
PCR product was done. Blottings with different concentrations of single-strand DNA 
(lpg/ml & lOp^g/ml) were compared in the nm23-Hl binding to nuclear matrix 
proteins. 
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Chapter 4 : Results 
4.1 Cell Culture 
Fifteen meningioma biopsies and one normal meningeal biopsy (Table 1) were 
obtained from the Prince of Wales Hospital, and were trimmed into small pieces of 
about 2mm in size. Meningioma cells were adherent in nature. Explant cell culturing 
technique was performed. Cell out-growth was observed from the explants within 
three days (Figure 1). Radial growth of the explant continued for about one week. 
Explants without any out-growing cells after one week were discarded and were 
classified as failum in cell line establishment. 
4.1.1 Meningioma Cell Culture 
Cells out-grown from various meningioma biopsies were in different 
morphological patterns under phase contrast microscope (Figure 2 & 3). Generally, 
meningioma culture-cells were large in size and polygonal in shape, with one 
exception in one specimen which gave elongated and star-like cells (Figure 3). 
Meningioma cells in culture usually grew in colonies and these colonies expended as 
more cells were formed (Figure 4). However, after prolonged culture (more than 18 
passages), tumor cells increased in cell size and decreased in growth rate. Cells 
became more flattened with the decrease of nucleus to cytoplasm volume ratio. 
Subsequently, these cells no longer divided and died soon. 
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4.1.2 Normal Meningeal Cell Culture 
Similar to the meningioma cell cultures, normal meningeal cell in culture had 
irregular and elongated shape, but with a larger cell size and more flattened 
appearance (Figure 5a). It usually grew in clusters, and sometimes it showed a regular 
and directional growing pattern (Figure 5b). After 14 passages, cell colony increased 
in size and became much irregular in shape. It soon died and detached from the culture 
dish or flask. 
4.2 Characterization of Cell Culture 
4.2.1 Chromosome Analysis 
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Normal meningeal cells in culture and four benign meningioma cell cultures 
were analyzed for their chromosome numbers. At the 6th passage, all the samples 
gave a wide range of chromosome numbers. Like all diploid eukaryotic cells, normal 
meningeal cells in culture had 46 chromosomes (Figure 6). While four meningioma 
cell cultures showed the number of chromosomes ranged from 44 to 47 (Figure 7，8, 
9 & 10). It was found that most of meningioma cells in culture usually contained 
abnormal chromosome numbers that were less than 46，mostly 44 or 45. 
4.2.2 Growth Kinetics Analysis 
Table 2 shows the results of growth kinetics of the four different benign 
meningioma and one normal cell meningeal cell culture. A fourteen-day cell counting 
was performed, and a sigmoid growth curve was obtained. Cell doubling time was 
determined by calculating the time required for the achievement of double cell number 
during the log phase of growth curve. Cells with two different passages (passage 5 & 
13) were compared. It was found that meningioma cell cultures had a shorter cell 
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doubling time than normal meningeal cell culture. Comparing the growth kinetics 
among four different meningioma cell cultures, at passages 5, all the samples showed 
similar growth rate. At passages 13，only sample #12 showed a stability in growth 
rate, whereas the others had a much longer cell doubling time compared to that at 
passage 5. Similar results were also observed in normal meningeal cell culture. This 
implied that cell growth slowed down after a long term culture. 
4.3 Morphological Study by Electron Microscopy 
4.3.1 Transmission Electron Microscopy 
Figure 11 shows TEM micrograph of normal meningeal biopsy. Most of the 
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normal meningeal cells were localized between collagen fibres. The cells were 
polygonal in shape, with some processes extending from the cell membrane. The cell 
nucleus contained nucleolus, abundance of heterochromatins at the periphery areas 
and extensive euchromatin. In the cytoplasm, some mitochondria could be seen. 
Figures 12a, b & c show the electron microscopic view of meningioma biopsy 
(Sample 12 in Table 1). Meningioma cells were surrounded by connective tissue. Both 
the cells in connective tissue and meningioma cells showed the loss of the cell 
architecture. Cell morphology was changed and it was difficult to distinguish between 
meningioma cells and surrounding support cells. Meningioma cells were irregular in 
shape and were larger as compared to the normal counterpart. The cell boundary could 
not clearly be discerned, and the cells had many processes. In cytoplasm, more 
mitochondria and vacuoles were found compared with the normal counterpart. 
Besides, some filamentous structures with directional pattern were found in 
cytoplasm. These filamentous structures may be the intermediate filaments. The cell 
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nucleus seemed to have abnormal chromatins. The arrangement of chromatins was 
different in tumor cells as compared to normal meningeal cells. 
Meningioma culture-cells usually had a larger cell size (Figure 13a). Many 
processes were found on the cell membrane (Figure 13b). Moreover, there were many 
mitochondria in the cytoplasm (Figure 13c). The compartments inside the 
mitochondria were absent or compressed, and appeared in circular, layered form. The 
cell nuclei were usually highly lobulated and irregular in shape (Figure 13d). The 
nuclei were only filled with euchromatin, the heterochromatin was likely absent, and a 
large irregular-shaped nucleolus was found. 
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4.3.2 Scanning Electron Microscopy 
Under SEM, the meningioma cells (Sample 12 in Table 1) appeared flattened (Figure 
14a & b). Extensive filapodia were extending from the surface to facilitate cell 
anchorage. Myriad microvilli were found on the cell surface. The nucleus was oval in 
shape. The cells were closely apposed. 
4.4 nm23-Hl Analysis 
4.4.1 Immunohistochemistry 
A total number of 24 cases of meningiomas, 15 females and 9 males, of 
different pathological grades (Table 3) were studied. Immunohistochemical staining 
on paraffin sections with anti-human nm23-Hl antibody showed positive reactivity in 
most of tumor samples. The appearance of nm23-Hl protein was found mainly in the 
cytoplasm, and nuclear staining was rare (15, 16 & 17). The staining was assessed as 
follows: (+++) strongly positive, (++) moderately positive, (+) weakly positive and (-) 
negative. An increase of nm23-Hl expression with respect to tumor invasiveness was 
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observed in female, but not in male patients. However, there was no significant 
relationship between nm23-Hl expressions in different age groups. 
For the immunohistochemical staining on cell cultures, a significant 
cytoplasmic nm23-Hl expression was obtained in both meningioma and normal 
meningeal cell cultures (Figure 18a - c). The staining was mainly localized in 
cytoplasmic regions surrounding the nucleus. The nm23-Hl staining seemed to have a 
network organization, even during cell division (Figure 19). No staining was found in 
nucleus. However, no obvious difference in nm23-Hl staining between normal and 
cancer counterpart was found. 
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4.4.2 Cell Total Protein Analysis 
One normal meningeal and two benign meningioma cell cultures (samples 7 & 
12) were analysed for their cellular proteins by anti-human nm23-Hl monoclonal 
antibody (Figure 20). All the three samples produced band of nm23-Hl protein at 
21kDa in molecular weight. The results were graded as positive if a more intensive 
band could be detected, while a faint band was evaluated as weakly positive. The 
nm23-Hl expression in meningioma cell cultures seemed to be higher than that in 
normal meningeal cell culture. 
4.4.3 Reverse Transcription Polymerase Chain Reaction 
The nm23-Hl expression of one normal and three benign meningioma cell 
cultures (samples 7, 12 & 13) were compared by using RT-PCR to analyze their 
mRNA level (Figure 21). The results were graded as positive if a distinct band could 
be detected, while a faint band was defined as weakly positive. All the samples gave 
the bands of nm23-Hl with 366 base pairs. The three benign meningioma cell cultures 
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seemed to have a higher nm23-Hl expression than the normal cell culture counterpart, 
but without any significant difference between each other. 
4.5 Immunohistochemistry for Steroid Hormone Receptors 
Paraffin sections of meningioma biopsies and meningioma cell cultures were 
determined in their progesterone (PGR) and estrogen receptors (ER) expressions. 
Table 3 summaries the results of the expression of PGR and ER in different 
meningioma samples. Among 24 samples of meningioma samples, all of them did not 
express ER, but did express PGR with one exception. Results showed that PGR was 
localized mainly in the nuclei (Figure 22，23 & 24). No cytoplasmic staining was 
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obtained. Both the female and male patients also expressed PGR. The level of PGR 
expression in all the samples were similar. Quantification in PGR expression was not 
done. 
Meningioma cell cultures showed a very weak staining with PGR, but they did 
not express ER. The weak signal of PGR staining in cell cultures could be observed in 
the nuclear region. No cytoplasmic staining was obtained. 
4.6 Nuclear Matrix Analysis 
4.6.1 Whole-mount Preparation 
Nuclear matrix-intermediate filament framework could be studied by the 
whole-mount preparation observed under TEM (Figure 25). In such preparation, most 
of the soluble cytoplasmic materials were removed after extraction, with the 
intermediate filaments remained in the cytoplasm. Intermediate filaments appeared in 
non-directional filamentous network system. Some intermediate filaments were 
associated with the outer nuclear envelope. The resultant dense materials inside the 
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nucleus was the nuclear matrix. Nuclear lamina surrounded the inner nuclear envelope 
that further associated with the intermediate filaments in the cytoplasm. The 
extensively dense matters inside the nucleus were the nucleolar residual. Between the 
nuclear lamina and nucleolar residual was internal matrix. The appearance of internal 
matrix was similar to that of intermediate filaments with the filamentous network. 
Some dense particles/granules were associated with internal matrix fibres. These 
fibres could be observed more clearly by the DGD thick section preparation. 
4.6.2 DGD Thick Section Study 
The morphology of nuclear matrix of meningioma cell culture was showed in 
0 
Figure 26a. After the nuclear matrix extraction, most of the cytoplasmic materials of 
the cell were removed, leaving the nuclear matrix. The nucleus was surrounded by 
nuclear lamina that was associated with the nuclear envelope and nuclear pore 
complexes. The nuclear lamina defined the shape and size of the nucleus and it 
separated the internal nuclear matrix from cytoplasmic intermediate filaments. Under 
high power view (Figure 26b & c)，the internal nuclear matrix fibres occupied the 
whole nuclear region. These matrix fibres connected between the nuclear lamina and 
residual nucleolus. There were many granular structures, usually occurs in clusters, 
associated with the matrix fibres that gave the fibres a rough appearance. A dense 
residual nucleolus were suspended by the nuclear matrix fibres. The organization of 
nucleolar matrix was quite different from that in internal matrix. The whole residual 
nucleolus was much denser than the internal nuclear matrix. 
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4.6.3 SDS-Polyacrylamide Gel Electrophoresis 
Figure 27 shows the 12% SDS polyacrylamide gel electrophoresis of nuclear 
matrix proteins of cultured meningioma cells (Sample 12 in Table 1) and 
intermediate filaments. Samples with different passages (passages 5 & 13) were 
compared. Many bands, including major and minor bands, were obtained in both 
nuclear matrix proteins and intermediate filaments of different samples. For nuclear 
matrix proteins, no significant difference in protein pattern between two samples was 
observed. However, some differences were found in intermediate filaments between 
samples with different passages. It was found that more intermediate filament proteins 
of low molecular weight were expressed in cells with higher passage numbers 
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(arrowed in Figure 27). 
4.6.4 Western Blotting for nm23-Hl Staining 
In order to localize nm23-Hl proteins in a cell after nuclear matrix extraction, 
Western blotting of nuclear matrix proteins and intermediate filaments was performed 
and was stained with anti-nm23-Hl antibody (Figure 28). It was found that nm23-Hl, 
which gave staining at 21kDa in molecular weight, was localized in the intermediate 
filaments. No detectable signal was observed in the nuclear matrix proteins. 
4.6.5 South-West Blotting of Nuclear Matrix for nm23-Hl cDNA 
The association of nm23-Hl PCR products and nuclear matrix proteins of 
meningioma cell cultures was done and the result is showed in Figure 29. Four strong 
binding sites of nm23-Hl cDNA to nuclear matrix proteins were found. These four 
binding sites were approximate 35, 22, 21 and 17kDa in molecular weight. In 
comparing the blotting using higher concentration of single-strand DNA (SS DNA), 
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there was no binding of nm23-Hl cDNA to nuclear matrix proteins obtained. This 
result showed a weak binding affinity between nm23-Hl cDNA and nuclear matrix 
proteins. 
4.6.6 Western Blotting for steroid hormone receptors 
Investigation of expression of progesterone and estrogen receptors in nuclear 
matrix proteins was performed. Transblotted membrane without primary antibody 
incubation was acted as control. Results indicated that no estrogen receptor expression 
was found, but progesterone receptor was expressed in nuclear matrix proteins. Two 
specific signals were obtained for progesterone receptor staining: bands with 
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approximately 45kDa and 85kDa in molecular weight (Figure 30). 
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Chapter 5 : Discussion 
5.1 Cell Cultures 
Normal meningeal and meningioma cells were adherent in nature. Explant 
tissue culture was performed and cells out-growing from the explants were observed. 
Meninges are layer of connective tissue covering the brain. Because of its fibroblastic 
appearance, normal meningeal cells in culture showed a flattened and elongated 
shape, and they grew in a regular and directional pattern. Meningiomas are tumors of 
meninges. Tumor cells usually gave a morphology different from their normal 
counterparts. Previous study on meningioma cell line establishment was reported 
(Korsgaard 1984). Similar to the meningioma cell culture in the present study, loss of 
cell architecture was found. Most of the meningioma cell cultures had pronounced 
cellular polymorphism with hyperchromatic nuclei. �� 
Moreover, meningioma cell cultures usually had abnormal chromosome 
numbers. In chromosome analysis, normal meningeal cell culture showed the majority 
of chromosome numbers of 46，similar to normal eukaryotic diploid cell. While 
meningioma cell cultures showed abnormal chromosome numbers ranging from 44 to 
47. Genetic alterations are the main factor for the development of tumors. Cell 
mutation may be caused by carcinogenic materials or during cell division. Deletion or 
translocation can lead to genetic alterations. Thus tumors usually had abnormal 
chromosome numbers. Previous reports showed that meningiomas were usually 
monosomy 21 in which one copy of the chromosome #21 was missing, or had the 
translocation of the chromosomes #14，17 or 21 (Atkinson and Schmidek 1991). 
Previous statistical findings showed that the number of chromosomes was less than 46 
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in meningiomas (Lopez-Gines 1995). In this study, the karyograph of both the normal 
and tumor samples was not investigated. 
Apart from abnormal genetic alterations, tumor cells are known to have a 
higher proliferation rate then their normal counterparts. Thus meningioma cell 
cultures might have a higher growth rate than the normal counterpart. However, the 
environment for growth of in vitro cell cultures was different from the in vivo system. 
Even though the medium and serum used in culture could supply a lot of nutrients for 
their growths, some unknown factors may not be present in the in vitro culture. One 
example of these factors may be the steroid hormone. As meningiomas were 
progesterone dependent, their growth could be stimulated by the presence of this 
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hormone (Morgan and Olson 1991; Olson 1987). In this study, the medium used was 
not supplemented with progesterone. For a long-termed in vitro cell culture, cells lost 
some growth factors leading to a decrease in growth rate, or cell differentiation. The 
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results observed in cultures were the alterations in cell morphology and physiology. It 
was believed that such changes might be controlled by the cells themselves due to 
some unknown gene expressions or inhibitions. But the detail of such changes were 
unclear. 
5.2 Electron Microscopy in Cell Morphology 
Under transmission electron microscope, differences between cell 
morphologies of normal meningeal and meningiomas biopsies were observed. In 
normal biopsy, meningeal cells were found within connective tissue such as collagen 
fibres. The cell always has a regular cell shape and smooth surface with some 
processes extending out from the membrane. The cell-to-cell contact is prominent. 
However, in meningioma biopsies, loss of cellular architecture was found. The 
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regular-patterned collagen fibres were lost. The tumor cells showed irregular shape 
with many large processes. Cell boundaries could not be clearly seen and cell 
infiltration was obvious. Moreover, there were many vacuole-, or vesicle-like bodies 
in the cytoplasm of tumor cells. These vacuoles/vesicles were extremely large in size, 
and some flocculent materials were localized inside them. This implied that 
meningioma cells might have secretions. Besides, some filamentous structures were 
found in cytoplasm. The nature of these filaments is not known. 
The nuclei in normal meningeal cells contained heterochromatins, 
euchromatins and nucleoli. The heterochromatins were densely packed chromatins 
and usually localized at the periphery region of nuclei. Most of heterochromatins are 
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non-functional in nature. The euchromatins were active chromatins that loosely fill up 
the whole nuclei. The round-shaped nucleoli were the sites for the synthesis of 
ribosomal constituents (Sheeler and Bianchi 1987). In meningioma cells, the 
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appearance of both heterochromatins and euchromatins was different from that of 
normal meningeal cells. The chromatins seemed to be in degraded form with a low 
contrast between heterochromatins and euchromatins (Figure 12b & c). The 
euchromatins in these nuclei were lost. The reason of this observation is not clear. 
Figure 15c shows another meningioma cell in which the nucleus contained 
euchromatins only. Similar results were obtained in meningioma cell cultures. Only 
euchromatin was found in the nucleus of meningioma cell culture. Since euchromatins 
were active chromatins which took part in gene expression, the dominant 
euchromatins indicated that the meningioma cells in culture were highly active in 
nature. Moreover, the shape of the nucleus was irregular and highly lobulated. 
Besides, an irregular nucleolus was found. In the cytoplasm, lots of abnormal 
mitochondria were found. Most of these mitochondria showed laminated structures 
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inside the membranes instead of a normal rectangular compartmentation. In 
comparison between the mitochondria in meningioma biopsies and cell cultures, large 
compartments without laminated structure were found in mitochondria of cells in 
biopsies. The significance of such changes in mitochondria in cultured cells was not 
clear. 
5.3 Nuclear Matrix • Intermediate Filament Frameworks 
5.3.1 Morphological Studies on nuclear matrix 
The nuclear matrix was first discovered by Berezney and Coffey in 1974 
(Berezney and Coffey 1974). TEM resin thin sections were used to study the 
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morphology of nuclear matrix in the past. Due to scattered electron in resin, an unclear 
image was obtained. The nuclear matrix is a 3-dimensional filamentous network 
structure. Using resin thin section, a 2-dimensional structure of nuclear matrix was 
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observed. Subsequently, an unembedded whole mount preparations was developed to 
provide an improvement in morphological study. In this case, the sample was placed 
in the electron beam and the biological materials gave sufficient electron scattering to 
form a high contrast image. However, the whole mount preparation is not an ideal 
method for studying the morphology in nuclear matrix. The cell is not thin enough to 
get a clear image of nuclear matrix. As shown in Figure 25, the thickness of the 
nucleus causes a dense, totally dark view in the nuclear region. The nucleus is masked 
by the nuclear lamina and intermediate filaments. Thus the whole mount preparation 
is suitable for the study of intermediate filaments. In order to obtain a clear 3-
dimensional structure of nuclear matrix, DGD thick section was developed (Capco 
1984; Fey 1986). DGD sections and after the removal of embedding medium give 
sharp and high contrast images. The 0.2p,m thick section could provide a 3-
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dimensional structure of nuclear matrix. As a result, DGD thick section is adopted for 
the study of the morphology of nuclear matrix. 
5.3.2 Nuclear Matrix Protein Analysis 
There were several methods of nuclear matrix extraction. Different methods 
were used for different purposes of study. In this study, extraction with ammonium 
sulfate developed by Fey et aL was used (Fey 1984). The resultant structure after the 
extraction is a nuclear matrix - intermediate filament (NM-DF) framework. As 
intermediate filaments are highly insoluble in several detergents, the NM-ff is 
dissolved in disassembly buffer which contains 9M urea. The dissolved NM-正 is 
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dialysed against assembly buffer for the re-precipitation of intermediate filaments. 
Due to the absence of urea in assembly buffer, most of the urea in dissolved sample is 
dialysed out that causes the re-precipitation of intermediate filaments. The nuclear 
matrix proteins remained in the solution. By ultracentrifugation, all the intermediate 
filaments are spinned down that separated from the nuclear matrix supernatant. Then 
the nuclear matrix and intermediate filaments can be resolved by gel electrophoresis. 
SDS - Polyacrylamide Gel Electrophoresis (SDS-PAGE) is a process for the 
separation of proteins according to their molecular weights through a solvent by an 
electric field. SDS is a kind of anionic detergent. It binds to the hydrophilic regions of 
proteins and separates them into component subunits. The anionic charge of SDS 
causes the denaturation of coiled polypeptides that all the peptides become linear 
forms with anionic charges. Proteins with different molecular weights are then 
separated in an electric field (Dunbar 1987). 
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5.3.3 Nuclear Matrix - Intermediate Filament 
Both intermediate filaments and nuclear matrix are in a filamentous network 
system, but they have different structures. In the whole mount preparation, a clear 
NM-EF framework was observed. The nuclear region was too dense to study in this 
specimen. The cytoplasmic residual was the intermediate filaments. Intermediate 
filament is a type of cytoskeleton with about lOnm in thick. It can be distinguished 
from the nuclear matrix fibres by its thickness. In DGD thick sections, nuclear matrix 
framework could be observed. Nuclear lamina was located at the peripheral regions of 
the nucleus. It was a nuclear matrix component associated with inner nuclear envelope 
and further connected to intermediate filament in the cytoplasm. Besides, a dense 
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nucleolar residual was found inside the nucleus. Between the nuclear lamina and the 
nucleolar residual was the internal nuclear matrix that appeared in an fibro-granular 
network throughout the nuclear region. The thickness of matrix fibres ranged from 
8nm to 18nm, and the diameter of granules was about 25nm. This measurement was 
similar to the results reported by Capco et al (1982). Apart from the thickness, 
intermediate filaments were smooth with no granular structure associated with them. 
Therefore cytoskeleton (intermediate filament) and nucleoskeleton (nuclear matrix) 
are of different network system. Moreover, the protein composition is different 
between nuclear matrix and intermediate filaments (Figure 27). The nuclear matrix 
proteins are complex while the intermediate filaments are mainly cytoskeletonal fibres 
of molecular weights ranged from 40kDa to 70kDa (e.g. vimentin has 58kDa). The 
complexity and difference of two samples imply they play different functional roles in 
cellular activities. In addition, cell cultures with higher passage contained more 
intermediate filaments below 80kDa in molecular weight, especial with 35，32 & 
25kDa. The increase in intermediate filaments in a cell might be due to the cell 
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differentiation in prolonged cultures. Prolong cultures got cell differentiation that their 
growth rate were slowed down with the cell shape became more flattened and increase 
in size. One of the differential by-products is the cytokeratins (Kim 1987). A relatively 
high expression of human keratins, AE1 & AE3，were found in differentiated 
esophageal carcinoma cell cultures (Or 1997). Thus, identification of intermediate 
filaments can be used as a marker in cell differentiation. 
5.4 nm23-Hl Analysis 
5.4.1 nm23 Expression in Meningiomas 
Human nm23 was a newly defined gene. Two isoforms of this gene were 
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reported, namely nm23-Hl (Steeg 1988a) and nm23-H2 (Stahl 1991). The chemical 
structures of the nm23-Hl & -H2 proteins were identical to the nucleoside 
diphosphate kinase (NDPK) A and B chains respectively (Gilles 1991). The actual 
functions of nm23 proteins have not been well established, but one of the major 
activities held by nm23-Hl was its involvement in tumors progression. In the present 
study, an increase in nm23-Hl expression with the tumor grade was found. 
Interestingly, this increased expression only appeared in female patients, but not in 
male patients. When determining the nm23-Hl protein level by Westem blotting, 
meningioma cells in culture expressed more nm23-Hl than the normal meningeal 
cells. This observation was also supported by the results obtained by RT-PCR. In the 
cell protein analysis, cell total proteins were extracted and precipitated. They were 
then separated according to their molecular weights by SDS-PAGE. The proteins were 
then transblotted onto nitrocellulose membrane for monoclonal antibody staining. In 
Figure 20, specific bands of nm23-Hl with 21kDa were observed. Meningiomas 
seemed to have a higher nm23-Hl expression than the normal counterpart. The nm23-
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H1 was a low molecular weight protein (20kDa). In cell total proteins analysis, only a 
small amount of nm23 protein was found. Because of its low-molecular-weight, 
nm23-Hl was easily degraded and lost in transblotting process. Thus the signal of 
bands of nm23-Hl after antibody staining was not strong enough for significant 
quantitative comparison. Then RT-PCR was performed for analysing the nm23-Hl 
mRNA level in cell cultures. The RT-PCR was a process of conversion of mRNA to 
cDNA and amplification of desired cDNA. In such experiment, the total RNAs were 
extracted from cell culture. Reverse transcription was performed in which all the 
RNAs were converted to cDNA by the activity of an enzyme celled reverse 
transcriptase. Then, by using specific nm23-Hl primers, amplification of nm23-Hl 
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cDNA was carried out by the process of PCR. Since equal amounts of different 
sample total RNA (2|xg) were used in this experiment, the outcome of the PCR 
products reflected the quantity of the nm23-Hl mRNA in cultured cells. Despite the 
small amount of nm23-Hl mRNA in a cell, RT-PCR could show a quantitative 
difference of this RNA between normal meningeal and meningioma cells in culture. 
Our result showed that the expression of nm23-Hl cDNA level is higher in three 
benign meningioma cells in culture compared with the normal counterpart. The higher 
level of the nm23-Hl cDNA implies that there is a relatively high expression in the 
mRNA level in tumor cells. Hence no post-translational regulation of nm23-Hl 
protein was found in meningioma, although this regulation was found in some other 
tumors. (Ayhan 1993; Biggs 1990; Chang 1994; Engel 1994; Hamby 1995; Lascu 
1992; Leone 1993a; MacDonald 1994). 
In general, nm23-Hl was suggested to be a metastasis suppressor gene. Its 
expression decreased with tumor metastasis in various tumors such as hepatocellular 
carcinomas (Iizuka 1995; Nakayama 1992), ovarian carcinomas (Viel 1995), gastric 
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carcinomas (Nakayama 1993) and melanomas (Florenes 1992; Xerri 1994). 
Transfection of nm23-Hl cDNA into highly metastatic melanoma cell lines showed 
the decrease in tumor metastasis (Leone 1991a). However, an inverse result of nm23-
H1 expression was observed in this study, which confirms previous results reported in 
neuroblastoma. The relatively high nm23-Hl expression in neuroblastomas was due to 
the mutation in nm23-Hl. An increase in nm23-Hl copy number in neuroblastomas 
(Takeda 1996) which caused an increase in DNA amplification (Leone 1993b)，and an 
overexpression of mRNA, proteins, compared with normal tissue. Besides, a "ser'^^-
gly" mutation in nm23-Hl protein in neuroblastomas was found (Chang 1994). These 
results indicated that molecular alteration in nm23-Hl was significant in tumor 
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aggressiveness in some tumors. Although the molecular analysis in nm23-Hl copy 
number and sequencing in meningioma has not been done, it is suggested that the 
mutation of nm23-Hl, such as increase in copy number, may be the major reason to 
answer why there is an increase in nm23-Hl expression with tumor malignancy in 
meningiomas. 
Results in immunohistochemistry showed a cytoplasmic nm23-Hl expression 
in both the meningioma paraffin-embedded sections and cell cultures. Particularly, in 
meningioma cell culture, the nm23-Hl staining appeared in a network system, in the 
cytoplasmic region surrounding the nuclei. Previous studies also indicated the 
cytoplasmic localization of nm23-Hl in many tumors, with a small amount of nuclear 
expression (Ayhan 1993; Barnes 1991; Caligo 1992; Giarnieri 1995; Haut 1991; 
Hennessy 1991; Howlett 1994; Iizuka 1995; Kraeft 1996; MacDonald 1995; Myers 
1996; Nakayama 1993; Nakayama 1992; Urano 1993; Viel 1995; Wang 1993; 
Watanabe 1995). The cytoplasmic localization of nm23-Hl might be caused by the 
functional activities of nm23-Hl proteins. The anti-nm23 antibody recognized the 
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mitotic spindle microtubules suggested that nm23 protein might have association with 
the synthesis of cellular microtubular activity (Biggs 1990). Also, a relatively high 
nm23 expression was found in late S-phase of the cell cycle suggesting that nm23 
might play a role in microtubule formation (Caligo 1995). In addition, positive result 
was obtained in Western blotting of intermediate filaments against anti-nm23-Hl 
antibody. Both the intermediate filaments and microtubules belonged to the family of 
cytoskeletons. This indicated that nm23-Hl might play a role in the synthesis of 
cytoskeletons. This also explained the cytoplasmic network appearance of nm23-Hl 
in meningioma cell cultures. Cytoskeletons are proteinaceous fibres that consist of 
bundles or groups of proteins. These fibres were associated with the nuclear envelope 
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and extended out in the cytoplasm. The network system of cytoskeletons gave skeletal 
support to cell in order to maintain the cell shape and motility. Since the 
cytoskeletons, especially the intermediate filaments, were associated with the outer 
nuclear envelope, and nm23-Hl proteins showed association with intermediate 
filaments and microtubules, thus the nm23-Hl expression was localized in cytoplasm 
surrounding the nuclei of culture-cells. 
5.4.2 Association between nm23-Hl cDNA and Nuciear Matrix 
DNA-binding ability is one of the feature of nuclear matrix. The binding site 
on DNA is defined as "Matrix Attachment Region" (MAR). The feature of binding is 
important for several cellular activities, such as DNA organization, and RNA and 
DNA metabolism. When transcription takes place, the MAR provides sites for the 
attachment of DNA to nuclear matrix. As the transcription factors are associated with 
nuclear matrix, the efficiency of transcription increased. In this study, we investigated 
the relationship between nm23-Hl cDNA and nuclear matrix. After the SDS-PAGE, 
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the nuclear matrix proteins were transblotted onto nitrocellulose membrane. Because 
most of the proteins on the membrane were denatured by SDS, they were left in TBS 
buffer overnight for the re-conformation of proteins. This process allowed the nuclear 
matrix proteins to convert back into in situ conformation for the DNA binding. Then 
single-stranded DNA was applied for non-specific site blocking before the DIG-
labeled nm23-Hl cDNA incubation. There were four different nuclear matrix 
proteins which were associated with nm23-Hl cDNA. This indicated that nuclear 
matrix might be involved in the transcription of nm23-Hl. When the membrane was 
blocked by a higher concentration of single-stranded DNA, no band was observed. 
This indicated that nm23-Hl cDNA has a weak association with the nuclear matrix. , 
Thus the nm23-Hl cDNA might have a MAR sequence. The MARs usually have AT-
rich sequence and many of the MARs coincided with transcriptional enhancers or 
display enhancer activity, and they were situated at close to or coincided with the 
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origins of replication (Boulikas 1993; Fey 1991). Considering the nucleotide numbers 
of nm23-Hl cDNA, there were 136 A, 134 C, 177 G and 129 T. Although it did not 
show the AT enrichment, this association depended on the conformation of the 
nuclear matrix proteins that nm23-Hl shows binding to nuclear matrix. The DIG-
labeled nm23-Hl double-stranded cDNA showed a weaker binding affinity than other 
single-stranded DNAs (Hakes and Berezney 1991a). This is why a weak association 
was found between nm23-Hl and nuclear matrix. A functional MAR appeared 
temporarily and was related to transcription that it played a modulatory role in gene 
expression (Boulikas 1993; Fey 1991). 
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5.5 Steroid Hormone Receptor Analysis 
5.5.1 Steroid Hormone Receptor Expression in Cell Cultures 
The growth of meningiomas could be stimulated by steroid sex hormones. 
Blocking of estrogen receptors showed a high predomination of growth stimulation by 
progesterone (Morgan and Olson 1991). Applying anti-progesterone agents resulted in 
tumor inhibition (Olson 1987). In this study, determination of the steroid hormone 
receptors expression in meningioma paraffin-embedded sections was performed. 
Results showed that more than 95% samples expressed the PGR, included samples 
from both male and female patients. However, no ER was expressed in all 
meningiomas. In general, meningiomas showed the pre-dominant expression of PGR. 
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Previous studies indicated that more than 85% of meningiomas expressed PGR, but 
only less than 35% expressed ER (Grunberg 1987; Koper 1994; Lesch and Fahlbusch 
1986; Markwalder 1984; Meixensberger 1992; Rubinstein 1994; Tonn 1994). In 
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addition, some reports mentioned no ER expression in meningiomas (Donald and 
Cahill 1994). These results implied that meningiomas were steroid hormone 
dependent, mainly the progesterone. Besides, the PGR staining in meningiomas was 
localized in nucleus with no significant difference in the PGR expression level among 
the samples. Nuclear expression of steroid hormone receptors have been reported. 
Lauber (1995) suggested that steroid hormone diffused into the nuclei and bound to 
their receptors. This binding led to certain gene regulations in order to stimulate the 
growth of target cells. The localization of steroid hormone receptors inside the nuclei 
was believed to be associated with nuclear matrices (Spelsberg 1988). The existence 
of steroid hormone receptors in nuclear matrices showed that they took part in the 
growth of meningiomas. 
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However, in meningioma cell cultures, no expression of both ER and PGR 
was found, although there was PGR positive staining in meningioma biopsy 
specimens. This indicated that the PGR was lost after in vitro culture. The loss of 
PGR in meningioma cell cultures may be due to the feedback effect of progesterone. 
The existence of steroid hormone receptors was dependent on the positive feedback by 
their corresponding hormone. In situ system provided sufficient factors for the growth 
of a cell that led to the normal gene regulation inside a cell. The presence of 
progesterone inside the body gave rise to a positive feedback on the gene expression 
of PGR that stimulated the PGR expression. This may explain why most of 
meningioma cells expressed progesterone receptors. On the other hand, no 
0 
progesterone was available in culture medium. Hence, cultured cells did not obtain 
any progesterone which caused the PGR gene to shut down. As the half-life of steroid 
hormone was very short, which was less than 20 hours, most of PGRs were degraded 
after several passages of culture. As a result, very few or no PGR was detected in cell 
culture after the 5th passages. The PGR expression in male patients could also be 
explained by the feedback system of progesterone. Progesterone is a female sex 
hormone. The abundance of this hormone in females causes the PGR expression. 
Although low level of female sex hormone was found in males, its presence led to the 
positive feedback and switch on the PGR expression. Thus the level of PGR 
expression did not show significant difference between females and males. 
5.5.2 Steroid Hormone Receptors Expression in Nuclear Matrices 
Immunohistochemistry showed that PGR, but not ER, was expressed in 
meningioma, and no obvious ER and PGR expression in cell cultures. However, 
Western blotting with anti-PGR antibody showed the association of PGR with nuclear 
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matrix proteins (45kDa & 85kDa). The feedback system caused the decrease in PGR 
level in cell cultures. Most of the PGRs in cell cultures were degraded. In nuclear 
matrix extraction, most of the soluble proteins were removed. The increase in 
concentration of nuclear matrix proteins led to the increase in the detection sensitivity 
of PGR. In addition to the high sensitivity of Western blotting, PGR was detected in 
nuclear matrix proteins analysis but not in immunohistochemistry. The steroid 
hormone receptors had been well detected in nuclear matrices. The presence of steroid 
hormone receptors in nuclear matrix indicate that they are involved in gene regulation. 
The steroid receptors are ligand-dependent transacting factors, composed of modular 
functional domains. There are regions for transactivation function, for ligand binding, 
0 
and a region comprised of two zinc-finger units for DNA binding. Steroid hormones 
diffuse into the nuclei and bind with their receptors that enhance the production of 
regulatory proteins which further activate gene expression for the growth of cell or 
enzyme activities (Lauber 1995). This is also why the growth of meningioma cells in 
culture will slow down in prolonged culture without progesterone supplement. The 
nuclear matrix is associated with both the steroid receptors and transcriptionally active 
genes, and with DNase I-hypersensitive sites. Thus the nuclear matrix is associated 
with many of the biological functions that are regulated by steroid hormones (Barrack 
1987a; Barrack 1987b; Barrack 1987c; Barrack and Coffey 1982; Berezney 1984). 
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Chapter 6 : Conclusion and Further Studies 
By explant culturing technique, meningioma cells out-grown from the explants 
were obtained. The tumor cells usually had a polygonal shape. Under TEM, 
meningioma cells appeared to lose their architecture with abnormal chromatin 
organization, abundant vacuoles, mitochondria and myriad cell processes extending 
from cell membrane. In cultures, tumor cells usually had highly-lobulated nuclei and 
abundant euchromatins. Most of the mitochondria in the cytoplasm were in laminated 
form. Abundant cell processes might increase cellular communication. All these 
indicated that meningioma cells were highly active in nature. Comparing with normal 
meningeal cells in culture, meningioma cells in culture had a faster growth rate and 
usually around 44 and 45 chromosomes. However, the growth of tumor cells soon 
subsided and died probably due to the shortage of growth factors. As meningiomas are 
progesterone dependent, lack of progesterone in culture medium would decrease the 
growth rate in prolonged cultures. 
Nuclear matrix is a high-salt resistant structure in nucleus and intermediate 
filaments are cytoskeletal fibres in cytoplasm. They are conversed structures that 
appear as a filamentous network system. Intermediate filaments have intermediate size 
of about lOnm in thickness. These fibres are connected to the outer nuclear envelope 
and are associated with nuclear matrix fibres inside the nucleus. Nuclear lamina is a 
nuclear matrix protein which is localized in perinuclear regions and is associated with 
the inner nuclear envelop. Nucleolar residue appears as a highly condensed group of 
fibres inside the nucleus. Internal matrix fibres range from 8 to 18nm thick with 25nm 
thick (in diameter) granules anchoring on them. These fibres appear in network 
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system and are connected to both the nuclear lamina and nucleolar residue. By SDS-
PAGE, the components of nuclear matrix and intermediate filaments can be resolved. 
The complexities and differences of these two structures indicate that they perform 
different cellular functions. Further study on the nuclear matrix components of 
meningiomas is needed. By using the 2-dimensional gel electrophoresis, the 
individual nuclear matrix proteins can be studied. In such experiment, nuclear matrix 
proteins can be separated according to their molecular weight at their isoelectric 
points. Cancer specific nuclear matrix proteins can be identified and analyzed. 
An investigation of nm23-Hl expression in meningiomas was made. Results 
of immunohistochemistry indicated an increase of nm23-Hl expression with 
0 
meningioma aggressiveness in female patients only. In Western blotting of total 
cellular proteins and RT-PCR, benign meningiomas seemed to have a higher nm23-
H1 expression than their normal counterpart, which was correlated with results in 
immunohistocytochemistry. Establishment of higher graded meningioma cell culture 
sample is required to obtain a complete comparison in nm23-Hl mRNA analysis by 
RT-PCR. nm23-Hl is a novel gene which carries tumor metastasis suppression 
function (Leone 1991a), and was down-regulated in most of the carcinomas (Florenes 
1992; Iizuka 1995; Nakayama 1993; Nakayama 1992; Viel 1995; Xerri 1994). Our 
results are in accordance to that observed in neuroblastomas (Chang 1994; Leone 
1993b; Takeda 1996), in which an increase in nm23-Hl expression in high grade 
tumor is believed to be caused by molecular mutation in nm23-Hl gene and the 
increased copy number of the nm23-Hl gene. 
nm23-Hl proteins were found to be associated with intermediate filaments, 
but not with nuclear matrix. Several studies have shown that nm23-Hl protein is 
localized in the cytoplasm (Ayhan 1993; Barnes 1991; Caligo 1992; Giarnieri 1995; 
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Haut 1991; Hennessy 1991; Howlett 1994; Iizuka 1995; Kraeft 1996; MacDonald 
1995; Myers 1996; Nakayama 1993; Nakayama 1992; Urano 1993; Viel 1995; Wang 
1993; Watanabe 1995) and is associated with microtubules (Caligo 1995). 
Our results of immunohistochemistry showed that PGR is dominant in >95% 
meningiomas over ER. However, all tumors in male and female patients expressed the 
PGR and there was no significant difference among the level of expression. In the in 
vivo system, progesterone in circulation causes the expression of PGR of the target 
cells. Although low level of progesterone is found in male patients, this hormone also 
causes the expression of PGR in target cells. It is difficult to quantify PGR expression 
between female and male patients. Our preliminary results showed that the nm23-Hl 
0 
cDNA could bind nuclear matrix proteins, and PGR was associated with nuclear 
matrix proteins. Lauber et al. (1995) suggested a functional role of steroid hormone in 
the regulation of gene expression. One specific chromatin acceptor protein, termed as 
"receptor binding factor -1” (RBF-1) for the avian oviduct progesterone was purified. 
Nuclear matrix provided sites of steroid receptor interaction with RBF-1. The RBF-1 
bound tightly to nuclear matrix associated DNA, and brought DNA into the proximity 
of the activated steroid receptor that promoted the gene expression such as c-myc as 
well as c-jun and c-fos (Schuchard 1991a; Schuchard 1991b). Nevertheless, the 
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Appendix 
Solutions and Buffers 
Cell Culture 
Culture Medium 
1. DMEM (GIBCO) 
2. 10% FBS (GIBCO) 
3. lOOIU/ml Penicillin (Sigma) 
4. lOOmg/ml Streptomycin (Sigma) 
Trypsin 
1. DPBS 
2. 0.02% EDTA (Sigma) 
3. 0.05% Type III Trypsin (Sigma) 
4. 0.001% Phenol Red 
Nuclear Matrix Extraction 
Cytoskeleton Buffer (CSK)~ 
1. 100mM KC1 (BDH) 
2. 3mM MgCl2 (BDH) 
3. lmM EGTA (Sigma) 
4. 1.2mM PMSF (Sigma) 
5. lOmM PIPES (pH 6.0) (Sigma)� 
6. 300mM Sucrose (BDH) 
7. 0.5%Triton X-100 (Sigma) 
Reticulocyte Standard Buffer (RSB) 
1. 42.5mM Tris-HCl (pH 7.4) (Sigma) 
2. 8.5mM NaCl (BDH) 
3. 2.6mM MgCl2 
4. 1.2mM PMSF 
5. l%Tween 40 (Sigma) 
6. 0.5% Sodium Deoxycholate (Sigma) 
Digestion Buffer (DB) 
1. 50mMNaCl 
2. 3mM MgCl2 
3. lmM EGTA 
4. 1.2mM PMSF 
5. lOmM PIPES (pH 6.0) 
6. 300mM Sucrose 
7. 0.5%Triton X-100 
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Assembly Buffer 
1. 0.15M KC1 
2. 25mM Imidazole HC1 (pH 7.1) (Sigma) 
3. 5mM MgCl2 
4. 2mM DTT (Sigma) 
5. 0.125mM EGTA 
6. 0.2mM PMSF 
Disassembly Buffer 
1. 8MUrea (Sigma) 




6. 1 % b-Mercaptoethanol (Sigma) 
Protein Assay 
Lysis Buffer 
1. 8M urea , 
2. 2% NP-40 
3. 2% b-mercaptoethanol 
RT-PCR 
RTMix �� 
1. 1X PCR Buffer (PERKIN ELMER) 
2. 1.5mM MgCl2 (PERKIN ELMER) 
3. 1.25mM dNTP (PERKIN ELMER) 
4. RNase Inhibitor (PERKIN ELMER) 
5. Reverse Transcriptase (PERKIN ELMER) 
6. Random Hexamer (PERKIN ELMER) 
7. 2mg RNA 
PCR Mix 
1. IX PCR Buffer 
2. 1.5mM MgCl2 
3. 1.25mM dNTP 
4. lmg Primers (Sense and Antisense) 
5. 3ml cDNA (Standardized in equal volume of RT's product) 
TE Buffer 
1. lOmM Tris-HCl (pH 8.0) 
2. lmM EDTA (pH 8.0) 
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SDS-PAGE 
SDS Sample Buffer 
1. 62.5mM Tris-HCl (pH 6.8) 
2. 10% Glycerol (Sigma) 
3. 2% SDS (Sigma) 
4. 0.05% b-mercaptoethanol 
5. 0.001 Bromophenol Blue (Sigma) 
Urea-SDS Sample Buffer 
1. 62.5mM Tris-HCl (pH 6.8) 
2. 10% Glycerol 
3. 2% SDS 
4. 0.05% b-mercaptoethanol 
5. 0.001 Bromophenol Blue 
6. 8MUrea 
Stacking Gel Mixture 
1. 0.125M Tris-HCl (pH 6.8) 
2. 5% Acrylamide/Bis 
3. 0.1% SDS , 
4. 0.1 % Ammonium Persulfate 
5. 0.001% TEMED 
Separating Gel Mixture 
1. 0.375M Tris-HCl (pH 8.8) 
2. 12% Acrylamide/Bis �� 
3. 0.1%SDS 
4. 0.1 % Ammonium Persulfate 
5. 0.0004% TEMED 
SDS Running Buffer 
1. 25mM Tris Base (pH 8.3) (Sigma) 
2. 0.192M Glycine (Sigma) 
3. 0.1%SDS 
Silver Staining 
Fix Solution 1 
1. 40% Ethanol (BDH) 
2. 10% Acetic Acid (BDH) 
Fix Solution 2 
1. 0.5% Glutaraldehyde (Polysciences) 
2. 30% Ethanol 
3. 8.3mM Potassium Tetrathionate (Sigma) 
4. 0.83M Sodium Acetate (Sigma) 
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Silver Nitrate Solution 
1. 11.8mM Silver Nitrate (BDH) 
2. 0025% Formalin (Mallinckrodt) 
Developer Solution 
1. 0.217M Potassium Carbonate (Sigma) 
2. 0.015% Formalin 
3. 0.047mM Sodium thiosulfate (Sigma) 
Stop Solution 
1. 0.413M Tris Base 
2. 2% Acetic Acid 
Western Blotting 
Western Blotting Buffer 
1. 20mM Tris Base (pH 8.3) 
2. 0.15M Glycine 
3. 20% Methanol (BDH) 
0 
South-west Blotting 
South-west Blotting Buffer 
1. lOmM Tris-Base (pH7.5) 
2. 50mM NaCl 
3. lOmM MgCl2 �� 
4. 0.5% Tween 20 
105 
0 
Micrographs and Tables 
Figure l a & b. Phase contrast micrographs of meningioma primary culture. 
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Figure 2. Phase contrast micrograph of meningioma cells in culture. 
(Sample 12; Scale bar = 200|Lim) 
Figure 3. Phase contrast micrograph of meningioma cells in culture 
(Sample 13; Scale bar = 200^im) 
Figure 4. Phase contrast micrograph of meningioma cells in culture. 
Note the cells grow in cluster (arrow). 
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Figure 5a & b. Phase contrast micrographs of normal meningeal cells in culture. 
Note the regular, directional growth pattern in (b). 
(Scale bar of 5a = 200|J.m; scale bar of 5b = 50^im) 
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Figure 6. Chromosome number analysis of normal meningeal cells in culture. 
Figure 7. Chromosome number analysis of meningioma cells in culture. 
(Sample 3) 
Figure 8. Chromosome number analysis of meningioma cells in culture. 
(Sample 7) 
Figure 6. Normal Meningeal Cells 
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Chromosome Number 
Figure 7. Meningioma Cells (Sample 3) 
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Figure 8. Meningioma Cells (Sample 7) 
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Figure 9. Chromosome number analysis of meningioma cells in culture. 
(Sample 12) 
Figure 10. Chromosome number analysis of meningioma cells in culture. 
(Sample 13) 
Figure 9. Meningioma Cells (Sample 12) 
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Figure 10. Meningioma Cells (Sample 13) 
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Figure 11. Transmission electron mircograph of normal meningeal biopsy. 
C: Cytoplasm; M: Mitochondrion; N: Nucleus; P: Cell Processes. 




























































Figure 12a, b & c. Transmission electron micrographs of meningioma biopsy. 
Note the presence of intermediate filaments in (a), myriad 
processes and bulk vacuoles in (b) and (c). 
C: Cytoplasm; F: Intermediate Filaments; M: Mitochondrion; 
N: Nucleus; Nu: Nucleolus; P: Cell Processes; V: Vacuole. 
(Scale bar of 12a = 9^m; scale bar of 12b = 9|Lim; 
scale bar of 12c = 8^m) 
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Figure 13a. Transmission electron micrograph of meningioma cells in culture. 
CM: Cell Membrane; N: Nucleus; NE: Nuclear Envelope; 
Nu: Nucleolus; M: Mitochondrion. 
(Scale bar = 6p,m) 
Figure 13b. Transmission electron micrograph of meningioma cells in culture. 
Note the myriad processes extended out of the cell. 
C: Cytoplasm; P: Myriad Processes. 





































Figure 13c. Transmission electron micrograph of meningioma cells in culture. 
Note the laminated mitochondria present in cytoplasm. 
M: Laminated Mitochondria; N: Nucleus; NE: Nuclear Envelope. 
(Scale bar = 5^m) 
Figure 13d. Transmission electron micrograph of meningioma cells in culture. 
Note the highly lobulated nucleus and prominant nucleolus. 
N: Nucleus; NE: Nuclear Envelope; Nu: Nucleolus. 









































Figure 14a & b. Scanning electron micrographs of meningioma cells in culture. 
F: Filapodia; N: Nucleus; P: Myriad Processes. 
(Scale bar of 14a and 14b = 5|Lim) 
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Figure 15. Micrograph of immunohistochemistry of anaplastic meningioma in 
paraffin section with anti-nm23-Hl antibody. 
Note the strong cytoplasmic staining of nm23-Hl protein. 
(Scale bar = 2 0 0 _ 
Figure 16. Micrograph of immunohistochemistry of atypical meningioma in paraffin 
section with anti-nm23-Hl antibody. 
Note the intermediate cytoplasmic staining of nm23-Hl protein. 
(Scale bar = 200|Lim) 
Figure 17. Micrograph of immunohistochemistry of benign meningioma in paraffin 
section with anti-nm23-Hl antibody. 
Note the weak cytoplasmic staining of nm23-Hl protein. 





























































































































































































































































































































































































































Figure 18a & b. Micrographs of immunohistochemistry of meningioma cells in 
culture with anti-nm23-Hl antibody. Note the perinuclear 
cytoplasmic staining of nm23-Hl protein (arrow). 
(Scale bar of 18a = 200|Lim; scale bar of 18b = 50^im) 
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Figure 18c. Micrograph of immunohistochemistry of normal meningeal cells in 
culture with anti-nm23-Hl antibody. 
Note the perinuclear cytoplasmic staining of nm23-Hl protein (arrow). 
(Scale bar = 200^m) 
Figure 19. Micrograph of immunohistochemistry of meningioma cells in culture 
with anti-nm23-Hl antibody during cell division. 
(Scale bar = 50jjjn) 
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Figure 20. Western Blotting of total cellular proteins with anti-nm23-Hl antibody. 
The nm23-Hl proteins with 21kDa were stained. Benign meningiomas 
seem to have a higher nm23-Hl expression than their normal 
counterpart. 
"1": Normal meningeal cells in culture; 
"2": Benign meningioma cells in culture (Sample 12); 
"3": Benign meningioma cells in culture (Sample 13). 
The results were graded as positive if a more intensive band could be 
detected, while a faint band was evaluated as weakly positive. 
Figure 21. Results of nm23-Hl RT-PCR. 
nm23-Hl cDNAs with 366 b.p. in length are observed. Benign 
meningiomas have a higher nm23-Hl expression compared to their 
normal counterpart. 
"1"： Normal meningeal cells in culture. 
"2": Benign meningioma cells in culture (Sample7); 
"3": Benign meningioma cells in culture (Sample 12); 
"4": Benign meningioma cells in culture (Sample 13). 
The results were graded as positive if a distinct band could be detected, 
while a faint band was defined as weakly positive. 
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Figure 20. Total Cellular Protein Analysis 
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Figure 22’ 23 & 24. Micrographs of immunohistochemistry of meningioma biopsies 
in paraffin section with anti-human progesterone receptor 
(PGR) antibody. 
Note the nuclear staining of PGR. 
(Scale bar of 22, 23 & 24 = 5 0 _ 
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Figure 25. Transmission electron micrograph of the whole mount preparation for 
nuclear matrix - intermediate filament framework study of meningioma 
cell in culture. 
Note the filamentous network system of intermediate filaments in 
cytoplasm and the dense nuclear matrix network of meningioma cell. 
IF: Intermediate Filaments; NM: Nuclear Matrix Network; 
Nu: Nucleolar Residual. 
(Scale bar = 9^m) 
Figure 26a. Transmission electron micrograph of DGD-embedded thick section of 
nuclear matrix in meningioma cell in culture. 
Note the filamentous network system of nuclear matrix. 
IM: Internal Matrix; NL: Nuclear Lamina; Nu: Nucleolar Residual. 
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Figure 26b & c. Transmission electron micrographs of DGD-embedded thick 
section of nuclear matrix in meningioma cell in culture. 
Note the filamentous internal matrix fibres associated with groups 
of granules. 
G: Granules associated with internal matrix fibres; 
IM: Intemal Matrix; NL: Nuclear Lamina; 
Nu: Nucleolar Residual. 
(Scale bar of 26a = 2^im; scale bar of 26b = l^im) 
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Figure 27. SDS-Polyacrylamide Gel Electrophoresis (PAGE) of intermediate 
filaments and nuclear matrix proteins of meningioma cell in culture. 
Note the increase in intermediate filaments expression in prolong culture 
(a: 35kDa; b: 32kDa & c: 25kDa). 
"1": Nuclear matrix proteins of meningioma cells at the 5th passage; 
"2": Intermediate filaments of meningioma cells at the 5th passage; 
"3": Nuclear matrix proteins of meningioma cells at the 13th passage; 
"4": Intermediate filaments of meningioma cells at the 13th passage. 
"5": Protein marker (BIO-RAD). 
Figure 28. Western Blotting of intermediate filaments and nuclear matrix proteins 
with anti-nm23-Hl antibody. 
Note the positive staining of nm23-Hl in intermediate filaments with 
21kDa in weight. 
"1": Intermediate filaments; 
"2": Nuclear matrix proteins. 
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Figure 28. Western Blotting for nm23-Hl 
, 
Figure 29. South-west blotting of meningioma cells' nuclear matrix with DIG-
labeled nm23-Hl cDNA. 
Note the four binding sites in nuclear matrix proteins (a: 35kDa; 
b: 22kDa; c: 21kDa & d: 17kDa) 
"1": Nuclear matrix proteins; 
"2": Protein Marker (BIO-RAD). 
Figure 30. Western blotting of intermediate filament and nuclear matrix proteins of 
meningioma cell cultures with anti-human progesterone receptor (PGR) 
and anti-human estrogen receptor (ER) antibody. 
Note the presence of PGR in nuclear matrix proteins (with 85 and 45kDa 
in weight). No ER was found in samples. 
"1": Intermediate filaments stained with anti-ER antibody; 
"2": Nuclear matrix stained with anti-ER antibody; 
"3": Intermediate filaments stained with anti-PGR antibody; 
"4": Nuclear matrix stained with anti-PGR antibody. 
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Figure 29. South-west Blotting 
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Table 1. Meningioma biopsies for cell line establishment. 
Highlighted samples are used as cell model in this study. 
Table 2. Growth kinetics of meningioma cells in culture. 
Table 1. Meningioma biopsies for cell line establishment 
Sample Type of Sample Pathological S e x ~ Age Maximum passage 
Grade obtained 
1 Meningioma Benign Female 34 1 
2 Meningioma Atypical Female 69 一 0 
3 Meningioma Benign Female 58 18 
4 Meningioma Benign Male 62 5 
5 Meningioma Benign Female 53 2 
6 Meningioma Atypical Female ‘ 79 0 
7 Meningioma Benign Female 44 16 
8 Meningioma Benign Female 69 6 
9 Meningioma Benign Male 65 5 
1 0 Meningioma Atypical Female 44 0 
1 1 Meningioma Benign Female 65 0 
12 Meningioma Benign Female 59 ^ 
13 Meningioma Benign Female 27 rs 
14 • Meningioma Benign “ Female “ 58 2 
1 5 Meningioma Atypical Male 62 3 
16 Normal — Female 53 14 
Table 2. Growth kinetics of meningioma cells 
Cell Doubling Time 
Passage Sample No. Sample type (Days) 
3 Meningioma \_M 
7 Meningioma 2.21 
5 12: Meningioma \_M 
12 Meningioma | ^ 
1^ Norma] Meninge 4.55 
3 Meningioma 3.95 
Z Meningioma 4 ^ 
1^ 12: Meningioma 2.33 
L3 Meningioma 6.44 
[6 Normal Meninge “ 10.46 
Table 3. The nm23-Hl, ER and PGR expression in meningioma biopsies paraffin 
sections correlated with their pathological grades, sex and age. 
Note the increased nm23-Hl expression with tumor progression in 
female patients. Most of the sample express PGR, and no ER expression 
is found. 
Highlighted samples are the in vitro cultured samples used as cell model 
in this study. 
The staining was assessed as follows: (+++) strongly positive, (++) 
moderately positive, (+) weakly positive and (-) negative. 
Table 3. nm23-Hl, ER and PGR expression in meningiomas 
Case Sex Age Grade ER Expression PGR NM23 
Expression Expression 
1 ¥ _ 58 Anaplastic - + ++ 
2 F 69 Anaplastic - + +++ 
3 F - 38 Atypical - + — + “ 
4 F 52 Atypical - 一 + ++ 
5 F 56 Atypical - + + 
6 F _ 66 Atypical - + -
7 F 69 Atypical - + j ^ 
8 F 79 Atypical - 一 + ++ 
9 F 27 Benign • + — ++ “ 
~ i 0 F ~ 4 ^ Benign - + + 
11 F 58 Benign - + — + “ 
12 F 58 Benign - — + �� + 
13 F 59 Benign - + 一 + “ 
1 4 F 65 Benign - + _ 
1 5 F 69 Benign - + + 
1 6 M 39 Anaplastic - + + 
17 M 54 Anaplastic - + + 
18 M ~ ^ Atypical - + -
19 M 62 Atypical - 一 + + 
20 M 64 Atypical - + + 
2 1 M 14 Benign - + + 
— 2 2 M ‘ 42 Benign - - — + “ 
23 M “ 55 Benign - + — + “ 
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